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CHAPTER I 
 
GENERAL INTRODUCTION 
 
Renal Medulla Overview 
 
Structure of Renal Medulla Mammalian kidneys are paired retroperitoneal 
organs located in the posterior part of the abdomen on each side of the vertebral 
column. The functional unit of the kidney is the nephron. Each human kidney 
contains about 106 nephrons. The essential components of the nephron are the 
glomerulus (including Bowman's capsule), the proximal tubule, the thin limbs, the 
distal tubule, and the collecting ducts (Figure 1). The straight portion of the 
proximal tubule, the thin limb segments and the straight portion of the distal 
tubule is also called loop of henle. There are two main populations of nephrons in 
the kidney: those originating from superficial and midcortical glomeruli which 
possess a short loop of henle (the cortical nephrons) and those originating from 
juxtamedullary glomeruli located near the corticomedullary boundary with a long 
loop of henle (juxtamedullary nephrons). (1) 
  The kidney can be divided into two major regions: an outer region called the 
cortex which contains glomeruli, and an inner region called the medulla (Figure 
1). On the basis of the specific segments of the nephron located at various levels 
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in the medulla, the medulla is further divided into an outer zone and an inner 
zone, with the outer zone subdivided into an outer and an inner stripe.  
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Figure 1. Diagram illustrating kidney structure. G= glomerulus; PCT=proximal 
convoluted tubule; PST=proximal straight tubule; TDL=thin descending limb of loop of henle; 
TAL=thin ascending limb of loop of henle; MTAL=medullary thick ascending limb; 
DCT=distal convoluted tubule; CCD=cortical collecting duct; OMCD=outer medullary 
collecting duct; IMCD=initial inner medullary collecting duct.  
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  Between renal tubules and vessels, interstitial cells and a loose, flocculent 
extracellular matrix constitute the renal interstitium. The amount of interstitial 
tissue in the cortex is limited, and the tubules and capillaries are often directly 
opposed to each other. However, in the medulla, the interstitium volume 
gradually increases, from 10% to 20% in the outer medulla to approximately 30% 
to 40% at the papillary tip of the inner medulla in both rats and rabbits.  
  Two types of cortical interstitial cells are identified: one that express ecto-5'-
nucleotidase, thus resembling a fibroblast (type 1 cortical interstitial cells) and 
another mononuclear or macrophage or dendritic cell-like (type 2 cortical 
interstitial cells). Type 1 cortical interstitial cells are the predominant form and 
also indicated as the site of erythropoietin production in the kidney (2). Type 2 
interstitial cells are believed to represent bone marrow-derived cells. In the renal 
medulla, three types of interstitial cells have been described (3). In the medulla, 
type 1 interstitial cells are characterized by predominant lipid-containing-droplets. 
They may resemble type 1 cells in the cortex, however, type 1 medullary interstitial 
cells do not express erythropoietin or ecto-5'-nucleotidase (4). They are present 
throughout the inner medulla and are also found in the inner stripe of the outer 
medulla. Type 2 medullary interstitial cells are virtually identical to the type 2 cells 
in the cortex. Type 3 medullary interstitial cells are pericytes that are adjacent to 
vasa recta. Type 2 and type 3 interstitial cells are free of lipid containing droplets 
and are especially abundant in the outer medulla.      
  Type 1 medullary interstitial cells have long cytoplasmic projections and are 
often arranged in rows with their long axis perpendicular to that of renal tubules 
5 
 
and vessels, thus resembling the rungs of a ladder (Figure 2). Often a single 
interstitial cell can be in direct contact with several vessels and tubules. 
Specialized cell junctions connecting interstitial cells and tubular and vascular 
cells in the renal medulla have been reported (5) (6), suggesting potential 
regulatory roles of type 1 medullary interstitial cells modulating the function of 
adjacent tubules and vessels. The number and size of the lipid droplets in the 
type 1 interstitial cells vary considerably depending on the species and the 
physiological state of the animal (7) (8), such as sodium and water intake. 
However, controversial data exist concerning how the lipid droplets are related to 
the diuretic state of an animal. The exact nature of these lipid droplets in type 1 
renal medullary interstitial cells remain largely unknown. The predominant type 1 
renal medullary interstitial cells (RMICs) are the subject of the present studies.  
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Figure 2. Light micrograph of the renal medullary 
interstitium from a normal rat. The lipid containing type 
1 medullary interstitial cells bridge the interstitial space 
between the adjacent thin limbs of henle (TL) and vasa 
recta (VR). (magnification x830). (Modified from Barry M. 
Brenner, The Kidney, 8th ed., 2008). 
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The Medullary Interstitial Environment The division of the kidney into cortical 
and medullary regions and the further subdivision of the medulla into outer and 
inner zones are of considerable importance in relating renal structure to its ability 
to concentrate urine. According to the countercurrent theory of urine 
concentration, the maximal urine concentration should be directly related to the 
length of the countercurrent multiplier system, which is comprised by the loop of 
Henle in a mammalian kidney (9). Although  this relationship between the ability 
to concentrate urine and the length of the loop of Henle seems to be more 
complex than originally proposed (10), all evidence obtained so far support that 
the renal ability of concentrating urine is intimately linked to the structure of the 
renal medulla including the specific transport properties and the unique 
architecture of the tubular and vascular structures there, which allow 
countercurrent multiplication (tubular structures) and countercurrent exchange 
(vascular structures) systems respectively. 
  The renal medullary interstitium exhibits many unique features not seen in any 
other organ or tissue of the body including 1-2 molar concentrations of sodium 
and urea, widely fluctuating tonicity, low blood flow, hypoxia, high concentrations 
of ammonia and pH changes. These features of renal medulla uniquely stress 
the cells residing in the medulla through hypertonicity, hypoxia and oxidative 
stress. 
  To concentrate urine, the loop of Henle acts as a countercurrent multiplier 
system, which creates a progressively increasing osmolar concentration 
(predominantly NaCl and urea) in the renal interstitium from the outer medulla to 
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the papillary tip of the renal medulla (Figure 3). The formation of the 
hyperosmotic medullary interstitium promotes water absorption in more distal 
nephron segments (ie. inner medullary collecting duct). Depending on the 
hydration status and resultant vasopressin levels, the mammalian kidney 
produces a urine of widely varying osmolarity. In situations of water depletion, the 
osmolarities in the papillary tip of renal inner medulla may be several times 
higher than that of systemic circulation (in humans ~1,200mosm in mice 
~5,000mosm versus ~300mosm), which would cause otherwise deadly 
consequences in other tissues. (11).  
  Besides high osmotic stress, renal medullary cells are also physiologically 
subjected to low blood supply and oxygen tension. The renal medulla receives 
less than 5% of the renal blood flow. In addition, the renal medullary circulation 
must satisfy the conflicting demands of preserving the cortico-medullary 
gradients of NaCl and urea, while delivering oxygen and nutrients to the medulla. 
This is achieved by countercurrent arrangement of the vasa recta organized in a 
hairpin form to minimize the wash-out of medullary solutes. However, the 
relatively low flow rates within the vasa recta and the oxygen consumption by 
tubular epithelium, in particular the medullary thick ascending limb, result in low 
medullary oxygen tension (12). It has been reported that the partial pressure of 
oxygen is of the order of 10 - 20 mm Hg in the inner and outer medulla, 
respectively, compared with ~50 mm Hg in the cortex (13). The pro-hypoxic 
potentially injurious environment in the renal medulla is supported by human 
diseased conditions. For instance, in sickle cell anemia, hypoxia sickling of the 
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red blood cells induces papillary necrosis and loss of urine concentrating 
capacity in these patients.  
 
 
 
 
    
 
Figure 3. The osmotic gradient in the human kidney. The osmolarity in the interstitium 
increases from 300 mOsm in the cortex to 1,200 mOsm at the papillary tip of inner 
medulla.  
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  Hypertonicity and hypoxia are also known to contribute to increased generation 
of reactive oxygen species (ROS). Although low levels of ROS are indispensible 
in biological processes such as intracellular signaling, immunity and defense 
against microorganisms (14-15), excessive ROS can cause oxidative stress, 
induce lipid, protein and nucleic acid modifications, DNA damage, and ultimately 
lead to cell dysfunction and death (16) (Figure 4). Under normal conditions there 
are significant amounts of ROS in the renal medulla (17) (18) (11). 
Immunohistochemistry staining for markers of oxidative modifications, 
nitrosylated tyrosine and 4-hydroxynonenal, shows higher levels of both markers 
in the renal medulla as compared to the renal cortex (Figure 5). The inner 
medullary interstitium appears to have the highest staining, consistent with the 
physiological increasing tonicity and hypoxia towards the papillary tip. 
  Taken together, the renal medulla is characterized by excess oxidative stress 
that results from rapidly changing interstitial tonicity, high osmotic stress, low 
blood flow, and low oxygen tension (18-20). Aging and diseased conditions such 
as the metabolic syndrome may further increase oxidative stress in the kidney 
and are associated with impaired renal function (21-22). Given that the renal 
medulla is an essential functional component of the kidney, strategies to maintain 
robust anti-oxidant mechanisms in the renal medulla is of paramount importance. 
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Figure 4. Overview of generation and antioxidant enzymatic detoxification of 
ROS.  
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Figure 5. Markers of oxidative stress in the mouse kidney. Immunohistochemistry 
using oxidative stress markers anti-nitrosylated tyrosine antibody (left panels) and anti-4-
hydroxynonenal antibody (right panels). Panels at the bottom show high magnification 
pictures of the renal inner medulla.  
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Anti-Stress Mechanisms in Renal Medulla The mechanisms allowing renal 
medullary cells to not only survive but also to function normally in this harsh 
environment are only partially characterized. A substantial body of evidence 
indicate important roles of the enhanced medullary expression and action of 
immediate-early genes (Fos and Jun), DNA damage inducible genes (GADDs), 
genes involved in cell cycle control and apoptosis (p53), heat shock proteins, and 
cyclooxygenase-1 and -2 (COX1 and COX2) and their derived prostaglandins (23) 
(11). Among them, the cytoprotective activity of COX2 in renal medulla is of note.  
  Cyclooxygenase is a key enzyme mediating the initial and committed step in the 
metabolism of arachidonic acid to the prostanoids (Figure 6) (24). COX catalyzes 
the conversion of arachidonic acid to PGH2. PGH2 is then converted to five 
bioactive prostanoids via distinct prostanoid synthases, including PGE2, PGI2, 
PGF2α, PGD2, and TxB2. The prostanoids interact with a group of G protein-
coupled receptors that mediate their diverse physiological effects. Since 
prostanoids are rapidly metabolically degraded, their actions are usually limited 
to the immediate vicinity of their synthetic sites.  
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Figure 6. Cyclooxygenase (COX) pathway of arachidonic acid metabolism. COX 
first converts arachidonic acid to PGH2 through cyclooxygenase and peroxidase activity. 
PGH2 is subsequently metabolized to five major bioactive prostanoids—PGE2, PGI2, 
PGD2, PGF2α, and TxA2—through their respective synthases, PGES, PGIS, PGDS, 
PGFS, and TxS. These prostanoids act on their specific receptors to exert their distinct 
biological effects: E-prostanoid receptors 1–4 (EP1–4), I-prostanoid receptor (IP), D-
prostanoid receptor (DP), F-prostanoid receptor (FP), and T-prostanoid receptor (TP).  
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  There are two isoforms of COX, designated COX1 and COX2, which differ in 
many important respects. COX2 represents an inducible and dynamically 
regulated form of PGH2 synthase, which is induced by physiological and 
pathophysiological stressors and plays important roles in the cellular response to 
stress. COX1 appears to be constitutively expressed in most tissues and plays a 
constitutive house-keeping role responsible for maintaining basal physiological 
function. The kidney expresses both COX1 and COX2 in distinct cellular 
compartments. COX1 is predominantly expressed in the collecting duct. In 
contrast, COX2 is expressed in cortical thick ascending limb and macula densa 
of renal cortex. In renal medulla, COX2 is mainly expressed in interstitial cells, 
where it functions as a key survival factor protecting against hypertonicity 
induced apoptosis in cell culture, as well as in vivo in water-deprived animals (24) 
(25) (19). This cytoprotective role of COX2 in the renal medulla is also supported 
by clinical studies showing that inhibition of COX2 by nonsteroidal anti-
inflammatory drugs (NSAIDs) is associated with necrosis of the renal medulla 
and papilla in patients, especially after dehydration (26) (27) (28), in which renal 
medullary cells are exposed to an extreme hyperosmotic environment. The 
NSAID blockage of  the protective effects of COX2 severely impairs cellular 
tolerance to this stress.  
  The protective activity of COX2 in renal medulla is likely to be mediated through 
several mechanisms. COX2-derived prostacyclin (PGI2) may promote renal 
medullary interstitial cell viability through activating the prostacyclin responsive 
nuclear transcription factor peroxisome proliferator-activated receptor 
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PPAR(29). Another study has shown that osmolyte accumulation, which is 
essential for cells to survive in the hypertonic environment of renal medulla, is 
dependent on COX2 activity (30). Moreover, renal medullary interstitial cells are 
in direct contact with vasa recta, suggesting an important role for these cells in 
maintaining an adequate blood supply to the renal medulla. COX2 derived PGE2 
may activate EP2 or EP4 receptor on vasa recta to modulate renal medullary 
vascular tone (31) (32). Disruption of the blood supply to the renal medulla by 
COX2 inhibition may therefore partially contribute to NSAID-associated papillary 
necrosis.  
     
Renal Medulla in the Regulation of Blood Pressure The kidneys are essential 
organs that are responsible for maintaining body electrolyte/fluid balance and 
normal blood pressure. Renal dysfunction has long been a recognized feature of 
essential hypertension (33). Originally, studies focused on the renal cortex, which 
is the site of glomerular filtration. Reduction of glomerular filtration and the 
morphological changes within cortical structures such as glomerulosclerosis have 
been well documented in patients with chronic hypertension. The involvement of 
the renal medulla in the regulation of blood pressure was proposed in the 1960s 
when Dr. Eric Muirhead reported that the medullary interstitial cells produced an 
anti-hypertensive substance, then designated as medullipin (34). Later studies 
suggested that the chemical nature of this blood pressure lowering substance 
might contain a product of arachidonic acid metabolism (35). Chemical ablation 
of renal medullary interstitial cells (RMICs) with bromoethylamine (BEA) leads to 
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systemic hypertension (36), supporting an indispensible role of these cells in the 
maintenance of blood pressure. In the mid-1980s Dr. Allen W. Cowley's group 
demonstrated a relationship between a reduction of renal medullary blood flow 
and experimental hypertension (37), and described the physiological role of renal 
medullary blood flow in the phenomena of pressure-natriuresis and diuresis.  
  COX-derived prostaglandins have been shown to play an important role in 
modulating sodium homeostasis and maintaining systemic blood pressure (38) 
(24). Clinical studies show that inhibition of cyclooxygenase in patients 
chronically ingesting NSAIDs or COX2 inhibitors is associated with the 
development of new cases of hypertension in the general population (39) (40). 
Importantly, animal studies show that a high sodium diet markedly increases 
renal medullary COX2 expression (41) (42), which may protect against sodium 
retention since inhibition of COX activity by intramedullary infusion of COX 
inhibitors causes sodium sensitive hypertension (43) (44). COX2 inhibition has 
also been reported to reduce renal medullary blood flow (45), and a reduction of 
renal medullary blood flow is known to cause sodium retention and hypertension 
based on pressure-natriuresis and diuresis theory.  
  The mechanisms underlying COX-derived prostaglandin modulation of sodium 
homeostasis and blood pressure maintenance have been partially elucidated. 
COX2 derived PGE2 or PGI2 and their corresponding EP2 and EP4 receptors or 
the IP receptor likely contribute to control of medullary blood flow via their  
vasodilator actions (31) (32). EP2 or IP receptor deficiency is associated with 
sodium sensitive hypertension (46) (47). Intramedullary infusion of PGE2 or EP2 
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agonist promotes renal sodium excretion in the setting of sodium loading (42). 
EP1 and EP3 receptors located in the thick limb and collecting ducts may also 
directly mediate sodium and water reabsorption through tubular epithelial cells 
(48-49). These studies support the role for COX-prostaglandin signaling in 
modulating sodium homeostasis and blood pressure. 
  In addition to impairing cell viability, reactive oxygen species (ROS) may also 
alter renal medullary blood flow through either vasodilation or vasoconstriction, 
and impact renal pressure-natriuresis, body sodium homeostasis and systemic 
blood pressure (33). The expression of both ROS-generating enzyme NADPH 
oxidase and ROS-removing enzymes SOD and catalase have been reported in 
the kidney (50) (51-52), consistent with physiological control of ROS level. 
Evidence suggests that increased oxidative stress in the renal medulla causes 
hypertension. Inhibition of anti-oxidant enzymes by intramedullary infusion of 
specific inhibitors reduces renal medullary blood flow and raises blood pressure 
in rats (53) (18). Furthermore, aging increases oxidative stress in the kidney and 
is associated with reduced renal function as well as increased incidence of 
hypertension (18). All the above observations suggest that maintaining strong 
anti-oxidant mechanisms in the kidney is of great importance to normal renal 
function and the regulation of blood pressure. 
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Sirtuin-1 (SIRT1) Overview 
 
Yeast Sir2 Gene and Its Homologues in Mammals Sir2 was originally 
identified in the yeast. Yeast Sir2 protein (silent information regulator 2) and its 
highly conserved homologues are nicotinamide adenine dinucleotide (NAD)+-
dependent histone/protein deacetylases (54-55). This catalytic reaction removes 
an acetyl group from the lysine side chains of a protein substrate, consumes 
NAD+ as a co-substrate, and generates nicotinamide (NAM) and 2'-O-acetyl-
ADP-ribose (56) (57) (Figure 7). As the intracellular level of NAD+ and its ratio to 
its reduced form NADH are dependent on cellular oxygen metabolism and redox 
state, Sir2 proteins function as molecular sensors of cellular energy balance (58) 
(59). As a co-substrate, increased NAD+ level is associated with increased 
deacetylase activity of Sir2. The product NAM, on the other hand, can inhibit Sir2 
enzymatic activity. Recently the NAD+ salvage pathway, which mediates the 
conversion of NAM back to NAD+, has been suggested to play a critical role in 
the cellular regulation of Sir2 activity (59). In addition to its deacetylase activity, 
Sir2 also has a mono-ADP-ribosyl transferase activity, which transfers ADP-
ribose to substrate proteins. 
  Sir2 homologues in mammals are called sirtuins. To date, seven sirtuin family 
members have been identified, SIRT1-7. SIRT1, SIRT5 and SIRT6 are primarily 
histone/protein deacetylases, whereas SIRT2 and SIRT3 have both deacetylase 
and mono-ADP-ribosyl transferase activities (60). SIRT4, on the other hand, is 
the only identified to have an exclusive mono-ADP-ribosyl transferase activity (61) 
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(62). Besides different catalytic functions and substrates, mammalian sirtuins 
also differ in regard to their subcellular localizations (63). SIRT1, SIRT6 and 
SIRT7 are mainly found in the nucleus, whereas SIRT2 is located in the 
cytoplasm, and SIRT3, 4 and 5 are located in the mitochondria. Among the 
mammalian sirtuins, SIRT1 is the most extensively studied. 
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Figure 7. Sirtuins catalyse a unique deacetylation reaction in which NAD is consumed 
as a co-substrate. During the reaction process, the substrate protein is deacetylated and 
NAD is cleaved to nicotinamide (NAM) and 2'-O-acetyl-ADP-ribose. NAM can be converted 
to nicotinamide mononucleotide (NMN) via nicotinamide phosphoribosyltransferase 
(NAMPT), followed by the conversion of NMN to NAD+ by NMN adenylyltransferase 
(NMNAT) in the NAD+ salvage pathway. 
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SIRT1 and Caloric Restriction Caloric restriction (CR) promotes health, 
reduces the incidence of obesity, diabetes, cancer, neurodegenerative diseases, 
and increases the lifespan of a wide range of organisms (64-66)). The underlying 
mechanisms mediating lifespan extension and beneficial health effects of caloric 
restriction include an important function of Sir2 gene, which was first 
demonstrated in yeast (67). Later studies have demonstrated an essential role 
for Sir2 homologues in mediating the beneficial effects of CR in worms, flies, as 
well as mammals (68). 
  Mammalian SIRT1 is required and sufficient for the induction of a caloric 
restriction phenotype in rodents (69). Caloric restriction increases SIRT1 
expression levels in several rodent and human tissues such as white adipose, 
liver, skeletal muscle, brain and kidney (70) (69). SIRT1-overexpressing 
transgenic mice exhibit a caloric restriction-like phenotype including lower body 
weight, reduction of fat mass, lower levels of total blood cholesterol, improved 
glucose homeostasis, increased metabolic rate, higher oxygen consumption, 
improved physical ability and delayed reproduction (71). In contrast, SIRT1-
deficient mice have been shown to be unable to adapt to conditions of caloric 
restriction (72). These studies are consistent with an essential role for SIRT1 in 
mediating the beneficial effects of caloric restriction in mammals. 
 
Pleiotropic Effects of SIRT1 Activity In addition to deacetylating histones, 
SIRT1 has been shown to deacetylate multiple transcriptional factors or co-
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factors including p53, FOXO, NFB, PPARγ and PGC-1α (73) (69) (Figure 8). 
Through this post-translational protein modulation, alters transcriptional activity or 
protein stability by SIRT1 exerts pleiotropic effects on the cellular stress 
response, inflammation, energy expenditure and cellular metabolism in multiple 
tissues and organs, in a tissue specific manner. Enhanced cell survival during 
stress conditions (e.g. oxidative stress or genotoxic stress) has been reported to 
be mediated through the interaction of SIRT1 with FOXO proteins and p53 (73). 
SIRT1 is anti-inflammatory as it represses the transcriptional activity of nuclear 
factor B (NFB) through deacetylation of its p65 subunit (74). By deacetylating 
nuclear receptor co-repressor (NCOR), SIRT1 blocks the activity of peroxisome 
proliferator-activated receptor- (PPAR-) and regulates fat mobilization from 
white adipose tissues (69, 75). SIRT1 directly modulates insulin secretion from 
pancreatic -cells via deacetylating and repressing the transcription of 
uncoupling protein 2 (UCP2) (76-77). SIRT1 is also known to regulate insulin 
signaling through deacetylation of the insulin receptor substrate 2 (IRS2) and 
repression of protein tyrosine phosphatase 1B (PTP1B) (78). Furthermore, 
cellular metabolic function controlled by mitochondrial number and function is 
modulated by SIRT1 via deacetylation of PPAR- co-activator 1 (PGC1) (75).  
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Figure 8. SIRT1 affects major cellular pathways by deacetylation of diverse substrate 
proteins. (Modified from Philip D. Lambert et al, Nature Reviews Drug Discovery, October 
2008. Reprint permission from Macmillan Publishers Ltd). 
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  Although no studies to date have shown a link between SIRT1 activity and 
human diseases or aging, a wealth of animal model data strongly support the 
pharmacological potential of SIRT1 activation as a strategy to treat or prevent 
metabolism or age related diseases (Figure 9). For instance, it has been reported 
that activation of SIRT1 by resveratrol, a naturally produced SIRT1 activator, 
improves metabolic syndrome in rodent models of obesity and type 2 diabetes 
(79) (80). Resveratrol improves insulin sensitivity, lowers glucose levels and 
extends lifespan of mice on a high fat diet. Newly developed specific and potent 
small molecule SIRT1 activators designated SRT compounds have also been 
shown to ameliorate the metabolic effects of type 2 diabetes in several rodent 
models (81). Moreover, transgenic mice overexpressing SIRT1 exhibit reduced 
lipid-induced inflammation, improved glucose tolerance and are protected from 
hepatic steatosis as compared with wild type mice (82). Overexpression of SIRT1 
specifically in pancreatic -cells (BESTO mice) improves glucose tolerance and 
insulin secretion in an intraperitoneal glucose tolerance test (76). Mice 
moderately overexpressing cardiac SIRT1 respond better to oxidative stress and 
exhibit less cardiac hypertrophy, apoptosis or fibrosis, cardiac dysfunction and 
expression of senescence markers with aging (83). Finally, both SIRT1 activators 
and overexpression of SIRT1 have been shown to slow in vitro neural cell death 
as well as in vivo neurodegeneration (84). In summary, activation of SIRT1 
appears to have broad favorable metabolic effects. 
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Figure 9. Multiple target organs in which SIRT1 activators can potentially have effects 
to treat diseases of aging. The effects on inflammation, mitochondriogenesis and 
metabolism may be seen in more than one tissue. The broad actions of SIRT1 activation in 
these target tissues are illustrated. (Modified from Philip D. Lambert et al, Nature Reviews 
Drug Discovery, October 2008. Reprint permission from Macmillan Publishers Ltd). 
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SIRT1 and the Kidney  SIRT1 is expressed in almost all mammalian tissues 
albeit at different levels. The expression pattern or functional role of SIRT1 in the 
kidney remains largely unknown.  
  A large body of evidence supports potent anti-oxidant functions of SIRT1 in 
diverse tissues and cell types (83, 85-86). This cytoprotective role for SIRT1 has 
also been reported in renal cells. Pre-treatment with the SIRT1 activator 
resveratrol reduces acute ischemia/reperfusion injury in rats (87). SIRT1 protects 
against oxidative stress induced apoptosis in cultured mesangial cells through 
deacetylation and inactivation of p53 (88). SIRT1 also protects mesangial cells 
from TGF-1-mediated apoptosis via deacetylating Smad7, which accelerates its 
degradation (89). In HK-2 cells SIRT1 is protective through activation of FOXO3 
and up-regulation of catalase (90).  
  Besides being an anti-stress molecule, SIRT1 also acts as a metabolic master 
switch. Caloric restriction or starvation has been reported to increase SIRT1 
expression in multiple tissues of the rodents including the brain, liver and kidney 
(70) (75). Interestingly intermittent fasting is reported to attenuate the progression 
of type 1 diabetic nephropathy in rats and is associated with increased renal 
SIRT1 expression (91), suggesting that SIRT1 may play a positive role in 
preserving renal functions in diabetic renal disease.  
  SIRT1 may also participate in blood pressure regulation. Miyazaki and 
colleagues reported that overexpression of SIRT1 in vascular smooth muscle 
cells (VSMC) reduced angiotensin II AT1 receptor (AT1R) expression (92). 
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Furthermore, Mattagajasingh and colleagues showed that inhibition of SIRT1 
inhibited vasodilation and decreased NO bioavailability. These studies suggest a 
role for SIRT1 in regulating vascular tone. SIRT1 is also reported to regulate 
sodium balance by repressing the transcription of the -subunit of the epithelial 
sodium channel ENaC through interacting with disruptor of telomeric silencing-1 
(Dot1) in cultured inner medullary collecting duct cells (IMCD) (93). However, its 
relevance to the in vivo condition of IMCD cells and renal function in general 
remains to be investigated. 
 
Overall Hypothesis 
 
Hypothesis: SIRT1 plays important roles in promoting resistance of renal 
medullary cells to oxidative injury. Three specific aims have been developed to 
test this hypothesis. 
Specific aim I: Characterize the histological distribution of SIRT1 expression in 
the mouse kidney. 
Specific aim II: Examine the cytoprotective role of SIRT1 in mouse renal 
medullary cells against oxidative injury. 
Specific Aim III: Examine the mechanism by which SIRT1 exerts cytoprotective 
functions in renal medullary cells. (This aim stands only if the answer to aim II is 
true.) 
 
 
  
29 
 
CHAPTER II 
 
MATERIAL AND METHODS 
 
Animals Mice were maintained in the animal facility of Vanderbilt University 
Medical Center, where they were housed at constant temperature with a 12-hour 
dark/12-hour light circle, and allowed free access to standard rodent chow and 
water. Wild type C57Bl/6J male mice at 8wks old were obtained from Jackson 
Laboratory.  
  The floxed-SIRT1 mouse was generated by Dr. Yansong Gu and coworkers 
(Harvard University Medical School, Boston, MA) (94), and deposited at the 
Jackson Laboratory (strain name: B6;129-SIRT1tm1Ygu/J). Mice with one allele of 
SIRT1 gene deletion were obtained by crossing a SIRT1floxed/+ mouse with a 
universal Cre mouse (EIIA-Cre mice on B6 background, kindly provided by Dr. 
Richard Breyer at Vanderbilt University, Nashville, TN). This mouse was further 
bred with C57Bl/6J to generate heterozygous SIRT1 knockout mice (SIRT1+/-) 
and their wild type littermates (SIRT1+/+). Male mice between 8 to 10wks of age 
were used in the present study. 
  To examine the effect of a high-salt diet on renal medullary COX and prostanoid 
synthase expression, mice were fed with either a high-salt diet (8% NaCl, 
Research Diet) or a normal-salt diet (0.3% NaCl) for 3 days.  
30 
 
  The effect of high salt diet on renal medullary NFB activity was examined in 
transgenic mice carrying a luciferase reporter driven by an NFB response 
promoter, HIV long-terminal-repeat (LTR) (HLL mice) (19). HLL mice were 
provided with either normal salt diet or high salt diet for 3 days, after which renal 
medullary luciferase activity was determined using a commercial luciferase assay 
kit, according to manufacturer's protocol (Promega Corp, Madison, WI). 
Luciferase activity was quantified with a luminometer (Monolight 3010, 
PharMingen, San Diego, CA) and adjusted for the total amount of protein (19).  
  The cellular location of NFB activation was examined using transgenic mice 
that carry an enhanced green fluorescent protein (EGFP) fusion protein under 
the control of an NFB response promoter LTR (95). The expression of EGFP 
was determined by immunofluorescence staining using an anti-EGFP antibody 
(Invitrogen, Carlsbad, CA) as previously described (95).   
  Tenascin-C promoter driven inducible Cre knockin mouse (TNC-CreER2-EGFP 
mouse) was generated in Transgenic Mouse/ES Cells Shared Core at Vanderbilt 
University. ROSA26-lacZ reporter mice and genotyping methods were previously 
reported (96). 
  All animal studies were approved by the Institutional Animal Care and Use 
Committee of Vanderbilt University 
 
Compounds SIRT1 activators SRT1720 and SRT2183 were provided by Drs. 
Christoph Westphal and Jill Milne (Sirtris, a GSK company, Cambridge, MA). For 
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1ml of 50mg/ml stock dosing solution used for in vivo studies, 50mg of SRT1720 
was added to 400l PEG400 and vortexed to form a homogenous suspension. 
Tween-80 (5l) was added to 595l water and vortexed. Then Tween-80/water 
was added into SRT1720/PEG400 and vortexed until homogeneous. In about 5-
10 min the suspension became a translucent-opaque suspension. The final 
vehicle composition was 40% PEG400, 0.5% Tween-80 and 59.5% water. 
SRT1720 (100mg/kg body weight) was given to mice by oral gavage once a day 
according to the company’s recommendation. For in vitro studies, SRT 
compounds were dissolved in DMSO. A final concentration of 0.5 to 10M of 
SRT1720 and a final concentration of 1 to 20M of SRT2183 were used. 
  COX2 selective inhibitor SC58236 was provided by Drs. Karen Siebert and 
Peter Isakson (Pfizer/Searle, New York, NY). For in vitro studies, compounds 
were dissolved in DMSO. A final concentration of 0.5M or 2.5M was used. 
  To test the hypothesis that  NFB is responsible for mediating high salt diet 
induced COX2 expression in the renal medulla, mice on normal salt diet were 
pretreated with an NF inhibitor, IMD-0354, (Sigma, St. Louis, MO) or vehicle 
for 2 days, followed by high salt diet for 3 days in the presence of IMD-0354 or 
vehicle. IMD-0354, dissolved in 0.5% carboxymethylcellulose (CMC, Sigma), was 
administered by gavage once daily at a dose of 8mg/kg, which effectively blocks 
NFB activation. Drug-free vehicle (0.5% CMC solution) was used as a control. 
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Unilateral ureteral obstruction (UUO) Mice (male, 8 weeks of age) were 
anesthetized with 50mg/kg body weight ketamine and 100mg/kg body weight 
xylazine. The left ureter was exposed via a lateral incision and ligated by two 
sutures at the level of the lower renal pole. Mice were sacrificed at day 3 or 7 
post operation. Both contralateral and obstructed kidneys were collected and 
assessed for gene expression, apoptosis and fibrosis.  
 
Immunoblot Protein concentration was determined using the bicinchoninic acid 
protein assay (Sigma). 50 micrograms of protein was loaded in each lane of a 10% 
SDS-PAGE mini-gel and run at 100V. Proteins were transferred to a PVDF 
membrane at 100V for 1 hour on ice. The membrane was washed 3 times with 
TBST (50mM Tris, pH7.5, 150mM NaCl, 0.05% Tween-20), incubated in blocking 
buffer (150mM NaCl, 50mM Tris, 0.05% Tween-20, and 5% Carnation nonfat dry 
milk, pH7.5) for 1 h at RT, and then incubated with primary antibody in blocking 
buffer overnight at 4°C. The primary antibodies used were: anti-SIRT1 antibody 
(Millipore rabbit polyclonal, 1:1,000; Sigma mouse monoclonal, 1:2,000), anti-
cleaved caspase-3 antibody (Cell signaling rabbit monoclonal, 1:200), anti-COX2 
antibody (Cayman rabbit polyclonal, 1:1,000), anti-COX1 antibody (Cayman 
rabbit polyclonal, 1:1,000), anti-Col1 antibody (MD Biosciences rabbit polyclonal, 
1:10,000), anti--actin antibody (Jackson ImmunoResearch Laboratories mouse 
monoclonal, 1:5,000), anti--tubulin antibody (Sigma mouse monoclonal, 
1:2,000). After three washes (15min each), the membrane was incubated with 
horseradish peroxidase–conjugated secondary antibody (Jackson 
33 
 
ImmunoResearch Laboratories, 1:5,000) for 1 h at RT, followed by 3 washes 
(15min each) with TBST. Antibody labeling was visualized by the addition of 
chemiluminescence reagent (PerkinElmer Life Sciences) and the membrane was 
exposed to Kodak XAR-5 film. Due to heterogeneous expression of SIRT1 in the 
kidney as well as distorted morphology of the obstructed kidney, tissue sampling 
(dissecting cortex from medulla) may easily introduce artifacts into data. For this 
reason, the entire kidney was homogenized and whole kidney lysates were used 
for all the immunoblot studies of Figures 4, 5, 6 and 8. 
 
Immunohistochemistry Deparaffinized 5µm sections were briefly incubated with 
3% H2O2, and then with primary antibody for 60 min, rinsed with Tris-buffered 
saline containing 0.1% Tween-20 and incubated with a biotinylated secondary 
antibody for 30 min. After three PBS washes (5min each), sections were 
incubated with horseradish peroxidase–conjugated anti-biotin labeling solution 
(ABC Elite Kit, Vector) for 30 min at 22°C followed by washing and incubation 
with 3,3-diaminobenzidine solution (DAB). Counterstaining with hematoxylin and 
eosin was then performed before examination under a light microscope. The 
primary antibodies used were as follows: anti-SIRT1 antibody (Millipore rabbit 
polyclonal, 1:500), anti-nitrosylated tyrosine antibody and anti-4-hydroxynonenal 
antibody (R&D biosystems mouse monoclonal, 1:500). 
 
Immunofluorescent Staining Kidney tissues were fixed in 4% 
paraformaldehyde and then incubated in 30% sucrose overnight. Cryostat 
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sections (5 µm) were blocked with 3% normal donkey serum for 20 min, and then 
incubated with primary antibody for 60 min at RT. After washing in PBS, the 
sections were incubated with a Cy2 or Cy3 conjugated anti-IgG secondary 
antibody (Jackson ImmunoResearch Laboratories, 1:200) for 30 min, washed in 
PBS for 5 times and examined using microscopy with a Zeiss Axioskop and spot-
cam digital camera (Diagnostic Instruments) or confocal microscope (Zeiss 
LSM510). The primary antibodies used for immunofluorescent studies were: anti-
SIRT1 antibody (Millipore rabbit polyclonal, 1:500), anti-aquaporin-1 (AQP1) 
antibody (Santa Cruz mouse monoclonal, 1:100), anti-Tamm Horsfall protein 
(THP) antibody (MP Biomedical goat polyclonal, 1:1,000), anti-aquaporin-2 
(AQP2) antibody (Santa Cruz goat polyclonal, 1:400), anti-COX2 antibody 
(Cayman rabbit polyclonal, 1:500). 
 
In Situ Hybridization In situ hybridization was performed as described 
previously (19). Mouse tissues were fixed in 4% paraformaldehyde and then 
embedded in paraffin. Sections (7 µm) were cut and hybridized at 50–55°C for 
approximately 18 hours with labeled riboprobes recognizing specific genes. After 
hybridization, sections were washed at 50°C in 50% formamide, 2  ´ SSC, and 
100M -mercaptoethanol for 60 minutes, treated with RNase A (10 mg/ml) at 
37°C for 30 minutes, followed by washes in 19 mM Tris, 5 mM EDTA, 500 mM 
NaCl (37°C), 2  ´SSC (50°C), and 0.1  ´SSC (50°C). Slides were dehydrated with 
ethanol containing 300 mM ammonium acetate. Photomicrographs were taken 
from slides dipped in K5 emulsion (Ilford Ltd., Knutsford, Cheshire, United 
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Kingdom) diluted 1:1 with 2% glycerol/water and exposed for 7 days at 4°C. After 
development in Kodak D-19, slides were counterstained with hematoxylin. 
Photomicrographs were taken with a Zeiss Axioskop microscope using bright-
field optics. 
 
Southern Blot  Crude ES cell DNA was first digested with restriction enzymes 
and run in 1% agarose gel. The DNA in the gel was depurinated by rocking it in 
0.25M HCl for exactly 10 min, followed by alkaline denaturation in 0.4M NaOH for 
3 x 15 min and shaking in 20XSSC for 5 min. The blot was set up from bottom to 
top: 1) A large dish filled with 20xSSC with glass plate on top of it to rest the gel, 
2) Two pieces of wick- blotting paper cut to the width of the gel and length such 
that the wick was in contact with the bottom of the dish, 3) Agarose gel that was 
turned upside down, with a nick in the bottom right hand corner for orientation, 4) 
Hybond N+ nylon membrane cut to the exact size of the gel, with a nick in the 
corner for orientation, 5) Four pieces of blotting paper cut to size of the gel, 6) 
Glass plate and additional weight to keep blot in place. The blot was transfered 
overnight. The next day, the gel and membrane was taken off together, and 
flipped. The wells were marked using a pencil. The membrane was auto X-linked 
with Stratalinker, followed by pre-hybridization at 65˚C for at least 1h. The probes 
were then added and the hybridization was continued at 65˚C overnight. The 
next day, the membrane was washed 3x for 10min at 65˚C and then exposed at -
80˚C for 4-7 days. Primers used for synthesizing 5' probe were: 5'-
TAGAGCAGGTGGTCCCAAACAT-3' and 5'-
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CCAGGAGCCAGGAAATAGCCTTA-3'. Primers used for synthesizing 3' probe 
were:  5'-GATGACGACTACACTGGGGAA-3' and 5'-
ACTGGGGCACCTTTGCTCTT-3'. 
 
Culture of renal medullary interstitial cells Mouse renal medullary interstitial 
cells were prepared as described (97-98). Briefly, 8 kidneys were harvested from 
donor C57Bl6/J mice under sterile conditions, and medullary regions were 
excised, minced, and suspended in Dulbecco’s Modified Eagle’s Medium (DMEM, 
Invitrogen) containing 10% (v/v) fetal bovine serum and penicillin/streptomycin. 
The pooled suspension containing renal medullary tissues from the donor mice 
was then injected intracutaneously at 3 or 4 different locations of the ventral 
abdominal wall of an isogeneric recipient mouse. Four days later, the recipient 
mouse was sacrificed, and the firm yellow nodules were removed and minced, 
and cells trypsinized in 0.05% trypsin-EDTA at 37ºC for 15 min, washed and 
pelleted at 1200rpm. The pellet was resuspended and cultured in DMEM 
supplemented with 10% fetal bovine serum and penicillin/streptomycin, at 37°C 
in 95% air /5% CO2 incubator. The cultured mouse renal medullary interstitial 
cells contained Oil Red O staining-positive lipid rich droplets, which is a 
characteristic feature of type 1 medullary interstitial cells (1). 
 
SIRT1 knockdown by Lentivirus carrying selective SIRT1 shRNA HEK293T 
cells were co-transfected with lentiviral pLKO.1 plasmid carrying SIRT1 selective 
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shRNA (Sigma MISSION shRNA library, SHCLNG-NM_019812), psPAX2 
packaging plasmid and pMD2.G envelop plasmid using FuGENE (Roche). 
Twelve hours later, the medium containing the transfection reagent was removed 
and replaced with fresh complete DMEM + 10% FBS + penicillin/streptomycin. 
Twenty-four hours later, the culture medium containing lentiviral particles was 
harvested from HEK293T cells and transferred to a polypropylene storage tube. 
Virus was stored in aliquots at -80ºC. Primary cultured mouse renal medullary 
interstitial cells (RMICs) were then infected with appropriate amount of lentiviral 
particles containing medium. Twenty-four hours later, virus containing medium 
was removed and replaced with fresh medium. Infected mouse RMIC were 
cultured for 3 days and then RT-PCR or immunoblot was performed to examine 
the efficiency of mRNA or protein knockdown. Controls included empty pLKO.1 
plasmid or pLKO.1 plasmid containing scrambled shRNA. In addition, two 
different SIRT1 selective shRNAs from Sigma were used side by side in all the 
knockdown experiments to determine whether they resulted in similar 
phenotypes.  
 
RT-PCR Total RNA was extracted from cultured mouse renal medullary 
interstitial cells by using TRIZOL reagent (Invitrogen) and reverse transcribed 
using high capacity cDNA reverse transcription kit (Applied Biosystems). The 
primers used for PCR were: SIRT1: sense 5’GCAACAGCATCTTGCCTGAT3’, 
antisense 5’GTGCTAC TGGTCTCACTT3’; SIRT2: sense 
5’CTTCCTGGGCATGATGAT3’, antisense 5’ACCCTGACTGGGCATCTAT3’; 
38 
 
SIRT3: sense 5’CAGCAACCTTCAGCAGTA3’, antisense 
5’CCGTGCATGTAGCTGTTA3’. PCR program used: 30 circles (94ºC, 30s; 58ºC, 
30s; 72ºC, 45s). 
 
quantitative RT-PCR Total RNA was extracted from renal tissues or cultured 
renal medullary interstitial cells using TRIZOL reagent (Invitrogen). Reverse 
transcription was performed using a high capacity cDNA reverse transcription kit 
(Applied Biosystems). Quantitative real time PCR was performed using Taqman 
gene expression assay system (Applied biosystems). The probes used were: 
Mm01168521_m1 (mouse SIRT1), Mm00478374_m1 (mouse COX2), 
Mm00477214_m1 (mouse COX1), Mm00801666_g1 (mouse Col1a1), 
Mm00802372_m1 (mouse Col4a1). Probes for eukaryotic 18S rRNA (4319413E) 
were used as endogenous control. Gene expression values were calculated 
based on the comparative threshold cycle (Ct) (method detailed in Applied 
Biosystems User Bulletin Number 2), normalized to the expression values of 18S 
rRNA, and displayed as fold induction relative to control.  
 
Crystal violet staining Cell viability was assessed using crystal violet staining 
(99-101). Culture medium was first removed and culture plates were washed with 
PBS. The remaining viable attached cells were stained with 0.5% crystal violet in 
50% methanol for 15 min at room temperature, and gently rinsed with water and 
dried. Crystal violet in each well of a 12-well plate was then re-dissolved by 500l 
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of 0.1M citrate sodium in 20% methanol, pH 5.4. 30 min later, the absorbance at 
570nm was read using a spectrophotometer. Untreated control wells were 
arbitrarily considered as 100% survival and the crystal violet absorbance in 
treated wells was compared to control wells to obtain the relative cell survival 
percentage. 
 
TUNEL (Terminal dUTP nick-end labeling) TUNEL assays of cultured renal 
medullary interstitial cells were performed according to manufacture’s protocols 
(In situ cell death detection kit, Fluorescein, Cat#11684795910, Roche). 
Vectorshield mounting medium for fluorescence with DAPI (Vector) was used. 
Immunofluorescent microscopy was performed using a Zeiss Axioskop and spot-
cam digital camera (Diagnostic Instruments). Apoptotic cell % was quantified by 
calculating the ratio of TUNEL-positive cells to DAPI stained total nuclei number 
on ≥15 random high power fields (HPF, 400X as final magnification).  
  For TUNEL assays on kidney sections, 5m thick sections of paraffin 
embedded tissue were deparaffinized and hydrated, quenched in 3% H2O2 for 15 
min to remove endogenous hydroxyl peroxidase activity, and then subjected to 
microwave antigen retrieval and proteinase K treatment to expose DNA. Slides 
were incubated in humidified chamber for 1 h at RT in a reaction solution 
containing TdT terminal transferase (Fisher), Bio-14-dATP (Gibco) and One-
Phor-All buffer (supplied with TdT terminal transferase). The reaction was 
terminated by washing in PBS, 2 x 3 min followed by 2% BSA in water for 10 min 
at RT, incubated in horseradish peroxidase conjugated anti-biotin labeling 
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solution (ABC Elite kit, Vector), and stained with 3,3-diaminobenzidine (DAB). 
Quantification of apoptotic cells was performed by counting TUNEL-positive cells 
in ≥6 random high power fields in the renal medulla (including outer and inner 
medulla) of one kidney section.  
 
Sirius red staining Collagen accumulation in kidney sections was determined by 
staining for Sirius Red (102), and quantified by image analysis. Analysis was 
performed without knowledge of treatment protocol. In brief, paraffin embedded 
sections were cut into 5m thick sections and deparaffinized. The slides were 
incubated in picro-sirius red solution (0.5g Sirius red F3B (C.I. 35782, Sigma) in 
500ml saturated aqueous solution of picric acid) for one hour, and then washed 
in two changes of acidified water (5ml acetic acid in 1L water). After physically 
removing most of the water from the slides by vigorous shaking or blotting with 
dam filter paper, the slides were dehydrated in three changes of 100% ethanol, 
cleared in xylene, and mounted in a resinous medium. A Zeiss Axioskop and 
spot-cam digital camera (Diagnostic Instruments) was used to capture 15-25 
non-overlapping fields per one kidney section at 200X for final magnification 
through crossed polars. Image analysis was performed using ImageJ with 
modifications of techniques described previously (103). Data was presented as 
the mean tubulointerstitial area occupied by collagen fibrils reactive with sirius 
red compared to total area (%). 
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Dual Luciferase Reporter Assay An 891bp human COX2 promoter driven firefly 
luciferase reporter construct was generously provided by Dr. Lee-Ho Wang 
(Department of Hematology, University of Texas Health Science Center at 
Houston, Houston, TX) (104). The COX2 reporter firefly luciferase plasmid and a 
plasmid containing renilla luciferase driven by the TK promoter (Promega) were 
co-transfected into primary cultured mouse renal medullary interstitial cells using 
FuGENE (Roche). Dual Luciferase assay kit (Promega) was used to measure 
both firefly and renilla luciferase activity in the transfected RMIC with or without 
treatment. Relative luciferase activity was defined as COX2 reporter firefly 
luciferase activity adjusted by renilla luciferase activity. Data is presented as fold 
induction compared to control group. 
 
Chromatin Immunoprecipitation Assay Chromatin immunoprecipitation Assay 
was performed according to the manufacture’s protocol (Millipore, ChIP Assay kit, 
Cat# 17-295). Cultured mouse renal medullary interstitial cells were cross-linked 
using 1% formaldehyde for 10 min at 37ºC. After washing twice using ice cold 
PBS containing protease inhibitors, cells were scraped into 1.7ml eppendorff 
tubes and spun down for 4 min at 2,000 rpm at 4ºC. The cell pellet was re-
suspended in SDS Lysis Buffer and incubated for 10 min on ice. The lysates 
were sonicated on ice to shear DNA to lengths between 200 and 1,000 base 
pairs, and then diluted 10 fold in ChIP Dilution Buffer with protease inhibitors. 
The immunoprecipitating antibody (Millipore, rabbit anti-SIRT1, working 
concentration 5g/ml) was added to the supernatant fraction for overnight-
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incubation at 4ºC with rotation (For a negative control, pre-immune IgG was 
added for immunoprecipitation). Then, Salmon Sperm DNA/Protein A Agarose 
Slurry (50ul into 2ml supernatant) was added for one hour-incubation at 4ºC with 
rotation. The agarose was pelleted by gentle centrifugation (700 to 1,000 rpm at 
4ºC, ~1min). The supernatant containing unbound, non-specific DNA was 
removed. The protein A agarose complex was washed for 3-5 min on a rotating 
platform with the washing buffers supplied with the kit. The precipitated complex 
was eluted from the antibody by adding freshly prepared elution buffer (1%SDS, 
0.1M NaHCO3), vortexed briefly and incubated at room temperature for 15 min. 
The agarose was then spun down, and the supernatant fraction (eluate) was 
transfered to another tube and elution was repeated. Eluates were combined and 
protein-DNA crosslinks were reversed by adding 5M NaCl (20ul into 500μl) and 
heating at 65ºC for 4 h. The reverse-crosslinked eluates were further treated with 
Proteinase K, and DNA was recovered by phenol/chloroform extraction and 
ethanol precipitation. Pellets were washed with 70% ethanol and air dried. Pellets 
were then resuspended in an appropriate buffer for PCR. The primers used were 
as follows: [-712, -396] region: sense 5’CAGCAGGGGGAAAATACCTT3’, 
antisense 5’CGGGATCTAAGGTCCT AACT3’; [-4166, -3946] region: sense 
5’GGACTGGCTAGAGACATTGA3’, antisense 5’ 
AGCAGGGAACACATGGATGA3’. PCR program used: 30 circles (94ºC, 30s; 60
ºC, 1min; 72ºC, 1min). 
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X-gal Staining Frozen sections were cut and fixed with cold formalin for 10 
minutes at 4ºC. After 3 PBS washes for 5 minutes each, the slides were rinsed in 
distilled water and washed in -gal wash buffer (0.1M Phosphate buffer, 2mM 
MgCl2, 5mM EGTA, 0.01% Sodium Deoxycholate, 0.02% NP40, pH7.3) for 10 
minutes at RT. Then, the slides were placed in X-gal staining solution (5mM 
Potassium Ferrocyanide, 5mM Potassium Ferricyanid, 1mg/ml X-gal in -gal 
wash solution) in a humidified chamber for 24 hours at 37ºC. After 2 PBS washes 
for 5 minutes each, the slides were rinsed with distilled water and mounted with 
aqueous mounting medium.  
 
Statistical Analysis Data are shown as mean±SEM. Statistical analysis was 
performed by using GraphPad Prism. Unpaired two-tailed student t tests were 
used to evaluate the differences in means between two independent groups. P < 
0.05 was considered to be significant. (* In the t test, the following assumption 
should be met: Each of the two populations being compared should follow a 
normal distribution, which can be evaluated by looking at the distribution of the 
data or by performing a normality test.)  
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CHAPTER III 
 
CYTOPROTECTIVE ROLES OF SIRT1 IN RENAL MEDULLA 
 
Introduction 
 
Mammalian SIRT1 belongs to a highly conserved family of nicotinamide adenine 
dinucleotide (NAD+)-dependent protein deacetylases and is widely expressed 
throughout most mammalian tissues (54-55). Because of its dependence on 
cellular NAD+ levels, SIRT1 activity responds to redox reactions in cell 
metabolism (58). Intriguingly, both overexpression of SIRT1 and activation of 
SIRT1 using the naturally occurring compound resveratrol or newly developed 
specific activators have been shown to promote cell resistance to different 
stressors (e.g. oxidative stress or genotoxic stress) in diverse tissues and cells 
(83, 85-86), This stress defensive function of SIRT1 is thought to contribute to its 
diverse beneficial  effects including protection from diseases (e.g. metabolic 
syndrome or neurodegenerative diseases) and extension of lifespan in rodents 
(57, 79, 81, 105).  
  Although SIRT1 has been extensively studied in many organs including the liver, 
pancreas, brain, adipose tissue and muscle, a functional role of SIRT1 in the 
kidney has only been partially established. SIRT1 has been suggested to play a 
protective role in diabetic renal disease (91) as well as in acute renal 
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ischemia/reperfusion injury models (106) (87) (107). In cultures, SIRT1 protects 
mesangial cells or HK-2 cells from oxidative stress or cytokines induced 
apoptosis (88) (89) (90). These observations are consistent with a cytoprotective 
role for SIRT1 in the kidney. 
  Notably, the renal medulla is characterized by pronounced oxidative stress that 
results from rapidly changing interstitial tonicity as well as high osmotic stress, 
low blood flow and oxygen tension (18-19, 108). Aging and diseased conditions 
such as the metabolic syndrome further increase oxidative stress in the kidney 
and are associated with reduced renal function (21-22). Given that the renal 
medulla is critical for normal kidney function including regulation of water and 
sodium balance as well as maintaining normal blood pressure (28, 33, 36, 98, 
109), strategies to maintain robust anti-oxidant mechanisms in the renal medulla 
is of paramount importance.  
  In this chapter, we characterized the histological distribution of SIRT1 in the 
kidney and examined the potential anti-oxidant role of SIRT1 in the renal medulla. 
 
Results 
 
SIRT1 is abundantly expressed in the renal medullary interstitial cells. Both 
immunoblot (Figure 10A) and qRT-PCR (Figure 10B, P<0.05) show significantly 
higher levels of SIRT1 expression in the renal medulla than in the renal cortex. 
Immunohistochemistry confirmed abundant nuclear SIRT1 immunoreactivity in 
the renal inner medulla (Figure 10C). Co-staining for SIRT1 (red) and the renal 
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segmental markers (green) showed abundant SIRT1 positive cells in the inner 
medullary interstitium (Figure 10D). Some aquaporin-2 (AQP2) positive collecting 
duct cells also expressed SIRT1 (Figure 10D, right panel). We confirmed SIRT1 
expression in the renal medullary interstitial cells as SIRT1 (red) co-localized with 
a COX2-reporter EGFP that is specifically expressed in these cells (Figure 10E). 
  
47 
 
 
  
 
48 
 
 
  
Figure 10. SIRT1 expression in mouse kidney. (A) SIRT1 protein expression in the C57Bl/6J mouse renal 
medulla (including outer and inner medulla) and the renal cortical region was examined by immunoblot. Each 
lane represents a lysate from a single mouse. (B) SIRT1 mRNA expression in the renal medulla and the 
cortex was examined by qRT-PCR (n=4, *P<0.05). (C) Immunohistochemistry for SIRT1 expression in the 
mouse kidney. (D) Immunofluorescent costaining for SIRT1 (red) and renal segmental markers (green): 
AQP1 (proximal tubule), THP (thick ascending limb), AQP2 (collecting duct). (G: glomerulus) (E) 
Immunofluorescence stained SIRT1 (red) in the EGFP-positive renal medullary interstitial cells of COX2 
promoter driven EGFP reporter transgenic mice. 
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SIRT1 protects cultured renal medullary interstitial cells against oxidative 
stress Because SIRT1 is abundantly expressed in the renal medullary 
interstitium where high levels of oxidative stress are present (see Figure 5, Page 
11), we tested the role of SIRT1 in promoting cellular resistance to oxidative 
stress using primary cultured mouse renal medullary interstitial cells (RMIC).  
  Down-regulation of SIRT1 was achieved using a lentivirus carrying a SIRT1 
selective shRNA. SIRT1 shRNA reduced endogenous SIRT1 protein expression 
by 85% (Figure 11A, P<0.0001). RT-PCR also showed that SIRT1 shRNA 
decreased SIRT1 mRNA expression, while SIRT2 and SIRT3 mRNA expression 
remained unaltered (Figure 11B). Exposure of RIMC to oxidative stress (250M 
H2O2, 12h) significantly reduced cell viability and this effect was accentuated by 
knockdown of SIRT1 (Figure 11C, 22±4% versus 51±5%, P<0.0001). TUNEL-
positive apoptosis also increased following H2O2 treatment (500M, 6h), which 
was further increased by knockdown of SIRT1 (Figure 11D, P<0.05). 
Sensitization to H2O2 treatment induced apoptosis by knockdown of SIRT1 was 
also confirmed by an immunoblot showing increased cleaved caspase-3 
expression (Figure 11E, P<0.001). 
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Figure 11. SIRT1 deficiency increases oxidative stress induced apoptosis in cultured 
renal medullary interstitial cells. (A, B) Primary mouse renal medullary interstitial cells 
(RMIC) were infected with lentivirus carrying SIRT1 selective shRNA or control virus. SIRT1, 
SIRT2 and SIRT3 expression were examined by immunoblot (A, densitometry, n=4, 
*P<0.0001) and RT-PCR (B). (C) Control or SIRT1 shRNA treated RMIC were challenged with 
H2O2 (250M) for 12 hours. Cell viability was examined by crystal violet staining (n=6, 
*P<0.0001 versus control virus treated cells with H2O2). (D) Control or SIRT1 shRNA treated 
RMIC were challenged with H2O2 (500M) for 6 hours. Cell apoptosis was examined by 
TUNEL assay (n=15, *P<0.05 versus control virus treated cells with H2O2). (E) Control or 
SIRT1 shRNA treated RMIC were challenged with H2O2 (500M) for 6 hours. Cellular 
apoptosis marker, cleaved caspase-3 expression, was examined by immunoblot (n=4, 
densitometry, *P<0.001 versus control virus treated cells with H2O2). 
51 
 
We next examined whether the SIRT1 activator resveratrol protected RMIC 
from oxidative stress. Resveratrol (5M) significantly enhanced the ability of 
RMIC to tolerate oxidative stress (500M H2O2, 12h) (Figure 12A, 54±8% 
versus 35±3%, P<0.001). Knockdown of SIRT1 using shRNA abolished the 
protective effect of Resveratrol (Figure 12A). Treatment of RMIC with SRT2183 
(5M), another specific and potent SIRT1 activator, also significantly reduced 
TUNEL-positive apoptosis following H2O2 treatment (Figure 12B, P<0.001). This 
was further confirmed by reduced cleaved caspase-3 level in H2O2 treated RMIC 
also treated with SRT2183 (Figure 12C, P<0.05). These observations are 
consistent with an anti-oxidant role of SIRT1 in renal medullary interstitial cells. 
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Figure 12. SIRT1 activation protects against oxidative stress induced apoptosis in cultured 
renal medullary interstitial cells. (A) Control or SIRT1 shRNA treated RMIC were pretreated with 
or without SIRT1 activator resveratrol (5M) and challenged with H2O2 (250M) for 12 hours. Cell 
viability was examined by crystal violet staining (n=6, †P<0.001 versus control virus treated cells 
with H2O2 without resveratrol). (B) RMIC were pretreated with or without SIRT1 activator SRT2183 
(5M) and challenged with H2O2 (500M) for 6 hours. Cell apoptosis was examined by TUNEL 
assay (n=15, †P<0.001 versus cells with H2O2 without SRT2183). (C) RMIC were pretreated with or 
without SIRT1 activator SRT2183 (5M) and challenged with H2O2 (500M) for 6 hours. Cellular 
apoptosis marker, cleaved caspase-3 expression, was examined by immunoblot (n=4, densitometry, 
†P<0.05 versus cells with H2O2 without SRT2183).  
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SIRT1 deficiency increases UUO injury induced apoptosis and fibrosis. To 
investigate the potential protective role of SIRT1 in kidney injury, we used the 
unilateral ureteral obstruction (UUO) model, which has been associated with 
increased renal oxidative stress (110-111). Although homozygous SIRT1 
knockout mice exhibit severe developmental defects (94), heterozygous SIRT1 
knockout mice develop normally, and their kidneys are histologically normal 
(Figure 13). qRT-PCR (Figure 14A, P<0.01) and immunoblot (Figure 14B, 
P<0.05) confirmed significantly decreased SIRT1 mRNA and protein expression 
in the kidney of heterozygous SIRT1 knockout mice (SIRT1+/-). A significant 
increase of SIRT1 protein expression was observed in the obstructed kidney at 
day 3 of both SIRT1+/+ mice (Figure 14C, P<0.0001) and SIRT1+/- mice (Figure 
14C, P<0.0001). In addition, SIRT1 induction was significantly less in the kidney 
of SIRT1+/- mice than in SIRT1+/+ mouse kidney (Figure 14C, P<0.001). 
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Figure 13. The kidney of heterozygous SIRT1 knockout mice develops normally. 
Representative pictures of PAS staining showing the histology of the renal cortex and renal 
medulla from wild type mice (SIRT1+/+) and heterozygous SIRT1 knockout mice (SIRT1+/-) 
(200X).  
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Figure 14. Reduced SIRT1 expression in the kidney of heterozygous SIRT1 knockout 
mice. (A) Relative SIRT1 mRNA expression level in the entire kidney of wild type mice 
(SIRT1+/+) and heterozygous SIRT1 knockout mice (SIRT1+/-) was examined by qRT-PCR 
(n=4, *P<0.01). (B) SIRT1 protein expression level in the entire kidney of SIRT1+/+ mice and 
SIRT1+/- mice was examined by immunoblot (n=6, densitometry, *P<0.05). (C) SIRT1 
expression in the entire kidney of SIRT1+/+ mice and SIRT1+/- mice following 3 days unilateral 
ureteral obstruction (UUO) was examined by immunoblot (n=4, densitometry, †P<0.0001 
versus contralateral kidney of SIRT1+/+ mice, ‡P<0.0001 versus contralateral kidney of 
SIRT1+/- mice, *P<0.001 versus obstructed kidney of SIRT1+/+ mice).  
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Renal cell apoptosis was predominantly seen in the renal medulla of mice 
following UUO (3d) as assessed by TUNEL. TUNEL-positive apoptosis was 
significantly greater in the renal medulla of SIRT1+/- mice than that of SIRT+/+ 
mice (Figure 15A, P<0.05). Increased apoptosis in the obstructed kidney of 
SIRT1+/- mice was further confirmed by higher levels of cleaved caspase-3 
expression when compared to SIRT1+/+ mice (Figure 15B, P<0.01). Following 7 
days UUO, sirius red staining, a marker of collagen, was greater in the 
obstructed kidney of SIRT1+/- mice versus SIRT1+/+ mice (Figure 15C, P<0.05). 
This result was confirmed by higher levels of type I collagen expression in the 
obstructed kidney of SIRT1+/- mice (Figure 15D, P<0.05). Thus SIRT1 deficiency 
increases renal apoptosis and fibrosis following UUO injury. 
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Figure 15. SIRT1 deficiency is associated with increased apoptosis and fibrosis in 
ureteral obstructed kidney. (A) Representative pictures (200X) and quantification of 
TUNEL-positive apoptosis in the renal medulla of SIRT1+/+ mice and SIRT1+/- mice 
following 3 days UUO (*P<0.05). (B) Immunoblot for the apoptosis marker cleaved caspase-
3 expression in the entire kidney of SIRT1+/+ mice and SIRT1+/- mice following 3 days UUO 
(n=4, densitometry, *P<0.01 versus SIRT1+/+ mice). (C) Representative pictures (200X) and 
quantification of sirius red staining on kidney sections of SIRT1+/+ mice and SIRT1+/- mice 
following 7 days UUO (*P<0.05 versus obstructed kidney of SIRT1+/+ mice). (D) Levels of 
type I collagen (Col1) protein expression in the entire kidney of SIRT1+/+ and SIRT1+/- mice 
following 7 days UUO were assessed by immunoblot (n=5, densitometry, *P<0.05 versus 
obstructed kidney of SIRT1+/+ mice). (open bar: contralateral kidney; filled bar: obstructed 
kidney).   
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SIRT1 activation reduces UUO injury induced apoptosis and fibrosis. In 
contrast to SIRT1 deficiency, treatment of wild type mice with the SIRT1 activator 
SRT1720 (100mg/kg/d) significantly reduced TUNEL-positive apoptosis in the 
medulla of the obstructed kidney following UUO (3d) (Figure 16A, P<0.05). 
Reduced apoptosis was further confirmed by reduced cleaved caspase-3 
expression in the obstructed kidney of SRT1720-treated mice versus vehicle-
treated mice (Figure 16B, P<0.0001). Furthermore, SRT1720 treatment 
significantly reduced sirius red staining (Figure 16C, P<0.05) and type I collagen 
(Col1) expression in the obstructed kidney following UUO (7d) (Figure 16D, 
P<0.05). Thus increasing SIRT1 activity decreases renal apoptosis and fibrosis 
following UUO injury, suggesting a protective role of SIRT1 in the obstructed 
kidney. 
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Figure 16. SIRT1 activation is associated with reduced apoptosis and fibrosis in ureteral 
obstructed kidney. (A) Representative pictures (200X) and quantification of TUNEL-positive 
apoptosis in the renal medulla of vehicle-treated or SIRT1 activator SRT1720 (100mg/kg/d)-
treated wild type mice following 3 days UUO (*P<0.05). (B) Immunoblot for cleaved caspase-3 
expression in the entire kidney of vehicle-treated or SRT1720-treated wild type mice following 3 
days UUO (n=4, densitometry, *P<0.0001 versus obstructed kidney of vehicle-treated mice). (C) 
Representative pictures (200X) and quantification of sirius red staining on kidney sections of 
vehicle-treated or SRT1720-treated mice following 7 days UUO (*P<0.05 versus obstructed 
kidney of vehicle-treated mice). (D) Levels of type I collagen (Col1) protein expression in the 
entire kidney of vehicle-treated or SRT1720-treated wild type mice following 7 days UUO were 
assessed by immunoblot (n=5, densitometry, *P<0.05 versus obstructed kidney of vehicle-
treated mice). (open bar: contralateral kidney; filled bar: obstructed kidney).  
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Discussion 
 
The present studies demonstrate that the stress responsive protein SIRT1 is 
preferentially expressed in the renal inner medulla including medullary interstitial 
cells. SIRT1 deficiency accentuates renal medullary cell apoptosis and renal 
fibrosis and conversely SIRT1 activation promotes the resistance of renal 
medullary cells to oxidative stress both in vitro and in vivo. These results 
therefore suggest that targeting SIRT1 with pharmacological activators might 
improve renal function in conditions that induce oxidative stress in renal medulla 
including ureteral obstruction. It remains to be determined if SIRT1 activation 
also protects renal cell viability in other types of kidney diseases including 
diabetic nephropathy and/or hypertensive nephropathy. 
Anti-oxidant function of SIRT1 has previously been reported in other organs 
such as the heart, neurons and pancreatic  cells (83, 85-86). In the kidney, we 
found that SIRT1 is abundantly expressed in the interstitial cells of renal inner 
medulla, where it also plays a critical role against excessive oxidative stress. This 
result is consistent with the observation that there are high levels of oxidative 
markers under physiological conditions in the renal inner medullary interstitium 
(Figure 5 in Chapter I). Multiple unique features of renal medullary interstitium 
are known to contribute to excessive oxidative stress including low blood flow 
and oxygen tension, high osmotic stress due to high concentrations of sodium 
chloride and urea (18, 112). Besides oxidative stress, high concentrations of 
ammonia and pH changes in the renal medullary interstitium may also 
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compromise cell viability (113). Whether the cytoprotective effect of SIRT1 
activity in the renal medullary interstitial cells is limited to oxidative stress remains 
to be investigated. The present study also shows SIRT1 expression in some 
renal inner medullary collecting duct cells in vivo. Whether SIRT1 exerts anti-
oxidant function in these cells was not determined. Nonetheless, a physiological 
role for SIRT1 in regulating the epithelial Na+ channel -subunit (-ENaC) 
expression has been reported in cultured renal inner medullary collecting duct 
cells (93). However, its relevance to the in vivo condition is to be investigated. 
Furthermore, increased oxidative stress and phenotypic changes have been 
reported in aging kidneys (21, 114-115). Given the reported anti-stress and anti-
aging nature of SIRT1 function (57, 83, 116-117), targeting SIRT1 by SIRT1 
activators may have therapeutic potentials to protect the kidney from developing 
age related renal diseases. 
SIRT1 responds to UUO injury as SIRT1 protein expression is induced in the 
kidney following ureteral obstruction (Figure 14C). Higher shifted bands 
recognized by anti-SIRT1 antibody are present in the obstructed kidney, which is 
consistent with the possibility of protein modification of SIRT1 (118-119). 
Distribution of SIRT1 in the obstructed kidneys remains similar to normal kidneys, 
with preferential expression in renal inner medulla (Figure 17). Abundant SIRT1 
expression is still present in the interstitial cells of the inner medulla. In addition, 
elevated SIRT1 immunoreactivity appears in both renal cortical and medullary 
cells. Whether this reflects potential stress-responsive functions of SIRT1 in other 
renal cell types besides renal medullary interstitial cells remains uncertain.  
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Figure 17. SIRT1 expression in the ureteral obstructed kidney. (A) Immunohistochemistry 
for SIRT1 expression in the obstructed kidney following 3 days UUO. (B) Immunofluorescent 
costaining for SIRT1 (red) and renal segmental markers (green) in the obstructed kidney: 
AQP1 (proximal tubule marker), THP (thick ascending limb marker), AQP2 (collecting duct 
marker). (G: glomerulus).  
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The present findings are consistent with a beneficial role for SIRT1 in 
protecting the kidney from fibrosis, supporting previous studies showing an anti-
fibrotic effect of resveratrol (120-122). Although the detailed mechanisms of renal 
fibrosis following ureteral obstruction are still incompletely understood, fibrosis 
appears to be a maladaptive response to injury. If apoptosis and loss of resident 
renal medullary cells are considered as primary injury following UUO, reduced 
apoptosis and loss of resident renal medullary cells by SIRT1 activity may 
consequently result in a reduced fibrotic response. In addition, the present 
observations that activation of SIRT1 promotes renal medullary interstitial cell 
viability and that SIRT1 activity reduces renal fibrosis following UUO injury further 
implies that renal medullary interstitial cells actively protected by SIRT1 are 
probably not the cells contributing to fibrosis. Other cell populations such as type 
3 medullary interstitial cells (perivascular pericytes) or infiltrating circulating cells 
may transform into fibroblasts. 
  In summary, the renal medullary environment is characterized by high oxidative 
stress. As the renal medulla is critical for the renal regulation of water and 
sodium balance as well as maintenance of normal blood pressure, maintaining 
robust anti-oxidant mechanisms in the renal medulla is of great importance. My 
work supports an important role of SIRT1 activity, which is tightly modulated by 
oxidative metabolism, in protecting renal medullary interstitial cells in the setting 
of oxidative stress. Recently specific and potent small molecule SIRT1 activators 
show therapeutic efficacy in alleviating symptoms in metabolic syndrome and 
neurodegenerative diseases. Targeting SIRT1 with SIRT1 activators may also be 
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a potential therapeutic strategy for minimizing or preventing renal damage or 
fibrosis resulting from increased oxidative stress. Such conditions include 
metabolic syndrome and aging. 
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CHAPTER IV 
 
THE ANTI-OXIDANT ACTIVITY OF SIRT1 IS PARTIALLY MEDIATED 
THROUGH INCREASING COX2 EXPRESSION 
 
 
Introduction 
 
In Chapter III, my work demonstrated that SIRT1 immunoreactive proteins are 
preferentially expressed in the mouse inner renal medulla, especially renal 
medullary interstitial cells. Both in vitro studies using primary cultured mouse 
renal medullary interstitial cells and in vivo studies using unilateral ureteral 
obstruction (UUO) model demonstrated an essential anti-oxidant activity of 
SIRT1 in the renal medullary interstitial cells. SIRT1 is known to regulate cellular 
response to oxidative stress via modulating the expression and/or activity of the 
cell cycle control protein FOXO, the DNA damage repair protein Ku70 and 
proteins involved in apoptosis, p53 and E2F1 in a tissue or cell type specific 
manner (123). However, the molecular mechanism by which SIRT1 exerts 
cytoprotective functions in renal medullary cells is to be investigated.  
  Renal medulla is a major site of prostaglandin synthesis. Prostaglandin 
signaling is known to protect multiple organs and tissues such as the liver, kidney, 
retina and neurons against injury of diverse causes (124-128). An important role 
of COX2 in protecting the renal medullary interstitial cells from apoptosis in 
hypertonic stress challenged cultured cells and in water-deprived animals has 
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been reported (19, 29-30, 129) (130) (24). Interestingly, several transcription 
factors that are important regulators of COX2 gene expression have also been 
demonstrated to be deacetylase substrates of SIRT1. These transcription factors 
include NFB and p53 (19) (74-75, 131-132) (19, 133). 
  To further explore the underlying mechanisms by which SIRT1 exerts potent 
anti-oxidant function in renal medulla, we set out to examine the potential 
interaction of SIRT1 and COX2, the two important survival factors that are co-
localized in the renal medullary interstitial cells. 
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Results 
 
SIRT1 regulates renal medullary interstitial cell COX2 expression in vitro. 
SIRT1 co-localizes with COX2 in renal medullary interstitial cells and COX2 
activity is an important survival factor in renal medullary interstitial cells (25, 30, 
129). To further explore the mechanism by which SIRT1 activation protects RMIC 
from injury, we examined whether SIRT1 activity promotes expression of COX2 
in RMIC. RMIC COX2 protein and mRNA expression was significantly increased 
by H2O2 (500M, 6h) (Figure 18A and 18B). H2O2-induced COX2 protein 
expression was nearly completely abolished by SIRT1 shRNA (Figure 18A). 
SIRT1 shRNA also dramatically reduced H2O2-induced COX2 mRNA expression 
(Figure 18B, P<0.0001).  
  Moreover, treatment of RMIC with the SIRT1 activator SRT2183 increased 
COX2 expression in a dose dependent manner (Figure 18C). In contrast, neither 
H2O2 nor down-regulation of SIRT1 altered COX1 expression (Figure 18A), and 
SIRT1 activator did not induce COX1 expression (data not shown), supporting a 
specific effect of SIRT1 on COX2 expression. Furthermore, induction of COX2 by 
hypertonic stress was not affected by down-regulation of SIRT1 (Figure 18D), 
suggesting that SIRT1 is specifically involved in the COX2 response to oxidative 
stress. 
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Figure 18. SIRT1 regulates COX2 expression in cultured renal medullary interstitial 
cells. (A) Wild type or SIRT1 knockdown cultured RMIC were challenged with H2O2 (500M) 
for 0, 3 or 6 hours. SIRT1, COX2 and COX1 expression were examined by immunoblot. (B) 
Wild type or SIRT1 knockdown RMIC were challenged with H2O2 (500M) for 0 or 6 hours. 
COX2 mRNA expression was assessed by qRT-PCR (n=4, *P<0.0001 versus wild type cells 
with H2O2). (C) RMIC were treated with SIRT1 activator SRT2183 (0, 5, 10, 20M) for 8 
hours, and COX2 expression was examined by immunoblot (n=4). (D) Wild type or SIRT1 
knockdown cultured RMIC were challenged with hypertonic stress (550mosm) for 0 or 6 
hours. SIRT1 and COX2 expression were examined by immunoblot.  
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  SIRT1 activity appears to regulate cultured RMIC COX2 expression at the 
transcriptional level, since SIRT1 shRNA significantly blunted H2O2 (250M, 
12h)-induced COX2 luciferase reporter activation (Figure 19A, P<0.0001). To 
determine whether SIRT1 physically associates with the COX2 promoter, a 
chromatin immunoprecipitation (ChIP) assay was performed on H2O2-treated 
RMIC. The presence of sequence from the mouse COX2 promoter region (5’ 
sequence -712 to -396) in the DNAs immunoprecipitated with SIRT1 antibody 
was confirmed by PCR (Figure 19B). SIRT1 associated COX2 promoter 
sequence was detected in both non-treated cells and H2O2-treated cells, 
suggesting that SIRT1 may be associated in a transcriptional complex on the 
COX2 promoter region. In contrast, PCR using primers recognizing a random 
DNA sequence about 4,000 bp upstream of COX2 gene transcription start site, 
showed no bands, supporting the specificity of the association of SIRT1 with 
COX2 promoter region. As a negative control, immunoprecipitation with normal 
rabbit IgG also showed no bands.   
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Figure 19. SIRT1 regulates COX2 gene expression at its transcriptional level. (A) 
COX2 luciferase reporter activity was measured in wild type or SIRT1 knockdown RMIC 
with H2O2 (250M) for 0 or 12 hours by using dual luciferase assay kit. (n=12, *P<0.0001 
versus wild type cells with H2O2). (B) ChIP assay was performed on non-treated or H2O2 
(500M, 3 hours)-treated RMIC using anti-SIRT1 antibody and PCR primers recognizing 
mouse COX2 5’ sequences upstream of the transcription start site [-712, -396] or [-4166,-
3946]. (C: immunoprecipitation with normal rabbit IgG). Data are representative of three 
independent experiments. 
 
A 
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SIRT1 regulates renal medullary interstitial cell COX2 expression in vivo 
Since SIRT1 activity regulates COX2 expression in vitro, we further investigated 
the role of SIRT1 in regulating renal COX2 expression in vivo. Abundant COX2 
induction (red) was observed primarily in the renal medulla of the obstructed 
kidney, but not in the contralateral kidney (Figure 20A). Co-staining confirmed 
COX2 expression (red) in renal medullary interstitial cells between AQP2 (green) 
stained collecting ducts (Figure 20A, right panel). Deletion of one allele of SIRT1 
gene significantly reduced COX2 induction in the obstructed kidney following 
UUO (3d) (Figure 20B, P<0.05). Furthermore, treatment of wild type mice with 
the SIRT1 activator SRT1720 (100mg/kg/d) markedly induced COX2 expression 
(red) predominantly in the renal medullary interstitial cells between AQP2 (green) 
stained collecting ducts (Figure 20C). This result was further confirmed by 
increased renal COX2 expression in SRT1720-treated mice versus vehicle-
treated mice as assessed by immunoblot (Figure 20D, P<0.05). Taken together, 
these in vivo observations are consistent with the in vitro results, and support an 
important role for SIRT1 to increase COX2 expression in renal medullary 
interstitial cells. 
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Figure 20. SIRT1 regulates COX2 expression in renal medullary interstitial cells in vivo. (A) 
Representative immunofluorescent pictures show COX2 induction (red) in the renal medulla of the 
obstructed kidney of wild type mice following 3 days UUO. Co-staining further shows induced 
COX2 (red) in renal medullary interstitial cells between AQP2 (green)-positive collecting ducts 
(right panel). (B) Immunoblot for COX2 expression in the entire kidney of SIRT1+/+ mice and 
SIRT1+/- mice following 3 days UUO (n=5, densitometry, *P<0.05 versus obstructed kidney of 
SIRT1+/+ mice). (C) Wild type mice were treated with vehicle or SIRT1 activator SRT1720 
(100mg/kg/d) for 5 days. Immunofluorescent co-staining shows that SRT1720 induces COX2 
expression (red) in renal medullary interstitial cells between AQP2 (green)-positive collecting 
ducts. (D) COX2 expression in the entire kidney of vehicle or SRT1720-treated mice was 
examined by immunoblot (n=4, densitometry, *P<0.05 versus vehicle-treated mice).  
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COX2 derived PGE2 protects cultured renal medullary interstitial cells from 
oxidative stress The ability of RMIC to tolerate H2O2 is dependent on COX2 
activity, since COX2 inhibition with SC58236 (2.5M) reduced cell viability from 
60±9% to 30±6% (Figure 21A, P<0.0001). Reduced cell resistance to oxidative 
stress by COX2 inhibition was further confirmed as increased H2O2-induced 
TUNEL-positive apoptosis was observed in RMIC treated with SC58236 (2.5M) 
(Figure 21C, P<0.001). Conversely, pre-incubation of RMIC with the COX2 
derived arachidonic metabolite prostaglandin E2 (PGE2) (100nM or 1M) dose 
dependently restored viability of SIRT1-deficient RMIC exposed to H2O2 (Figure 
21B, 69±6%, 82±9% versus 43±5%, P<0.05). TUNEL assay (Figure 21D, 
P<0.05) and immunoblot for cleaved caspase-3 expression (Figure 21E, P<0.05) 
further showed reduced H2O2-induced apoptosis in SIRT1-deficient RMIC treated 
with PGE2 (100nM). Taken together, these observations support SIRT1-
dependent COX2 induction as an important anti-oxidant mechanism in the renal 
medullary interstitial cells. 
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Figure 21. COX2 activity and its derived PGE2 protect cultured renal medullary interstitial 
cells from oxidative stress. (A, B) Wild type or SIRT1 knockdown cultured RMIC were 
pretreated with COX2 selective inhibitor SC58236 (0.5M, 2.5M) or PGE2 (100nM, 1M) and 
challenged with H2O2 (250M) for 12 hours. Cell viability was examined by crystal violet staining 
(n=6, *P<0.0001 versus cells with H2O2 alone, †P<0.0001 versus SIRT1 knockdown cells with 
H2O2 without PGE2, ‡P<0.05 versus SIRT1 knockdown cells with H2O2 and 100nM PGE2). (C, D) 
Wild type or SIRT1 knockdown RMIC were pretreated with SC58236 (2.5M) or PGE2 (100nM) 
and challenged with H2O2 (500M) for 6 hours. Cell apoptosis was examined by TUNEL assay 
(n=15, *P<0.001 versus cells with H2O2 alone, †P<0.05 versus SIRT1 knockdown cells with H2O2 
without PGE2. (E) Wild type or SIRT1 knockdown RMIC were pretreated with 100nM PGE2 and 
challenged by H2O2 (500M) for 6 hours. Cellular apoptosis marker, cleaved caspase-3 
expression, was examined by immunoblot (n=4, densitometry, *P<0.05 versus SIRT1 knockdown 
cells with H2O2 without PGE2).  
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Discussion 
 
COX2 is required for renal medullary interstitial cell survival against hypertonic 
stress. Interestingly, a stress defensive protein SIRT1 is also found preferentially 
expressed in the renal inner medulla including medullary interstitial cells. In this 
chapter, I was able to find data to support that these two essential survival 
factors COX2 and SIRT1 are uniquely linked in the renal medullary interstitial 
cells, and they together exert anti-oxidant functions. By showing that SIRT1 
regulates COX2 induction in the setting of oxidative stress and that PGE2 
rescues oxidative stress-induced apoptosis in SIRT1-deficient cells, the present 
study places COX2 induction and PGE2 production downstream of SIRT1 in the 
renal medullary interstitial cells in the setting of oxidative stress. 
COX2 has been shown to be a pre-requisite for renal medullary interstitial cell 
survival from hypertonic stress (19, 25, 29, 129). Previous study by Hao and 
colleagues suggests that hypertonicity activates COX2-derived prostacyclin 
(PGI2) production, which promotes cell viability through PPAR(29). The present 
study, however, identified a cytoprotective effect of PGE2 on renal medullary 
interstitial cells against oxidative stress. Protective effects of COX2 derived 
PGE2 have been reported in multiple organs and tissues such as the liver, 
kidney, retina and neurons against injury of diverse causes (124-128). The 
underlying molecular mechanisms involve an activation of PGE2 coupled cAMP-
PKA or PI3K-Akt signaling pathways (128, 134-136). These kinases may 
therefore be responsible for the anti-apoptotic effect of COX2 derived PGE2 
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observed in my study in the setting of oxidative stress. Interestingly, RT-PCR 
analysis showed the presence of two PGE2 receptors EP1 and EP4 in the 
cultured renal medullary interstitial cells (Figure 22). Interestingly, the expression 
of EP4 mRNA dramatically increased following H2O2 treatment, implicating a 
potential role for EP4 receptor in response to oxidative stress.  
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Figure 22. EP4 agonist protects cultured renal medullary interstitial cells from 
oxidative stress. (A) The expression of PGE2 receptors EP1-4 in the non-treated or 500M 
H2O2 (6h)-treated cultured mouse renal medullary interstitial cells was examined by RT-PCR 
using specific primers. (P: positive control using RNA extracted from mouse renal medullary 
tissues). (B) Wild type or SIRT1 knockdown cultured RMIC were pretreated with EP4 
agonist (50nM) and challenged with H2O2 (500M) for 12 hours. Cell viability was examined 
by crystal violet staining (n=6, ***P<0.0001). 
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  Given the fact that neither UUO injury nor the SIRT1 activator induces COX2 
expression in renal medullary collecting duct cells in vivo, the SIRT1-dependent 
COX2 induction and PGE2 production may be a specific effect on renal 
medullary interstitial cells. Since prostaglandins can act through both autocrine 
and paracrine mechanisms, it is possible that SIRT1 in renal medullary interstitial 
cells may protect adjacent renal tubules and vessels through locally diffused 
PGE2. Different mechanisms are reported in cultured mesangial cells, where a 
cytoprotective role of SIRT1 against oxidative stress or TGF-1 induced 
apoptosis is mediated via deacetylating p53 or Smad7 respectively (88) (89). 
However, whether SIRT1 interacts with these proteins in renal cells in vivo 
remains undetermined.  
  The present finding is supportive of a regulatory role of SIRT1 on COX2 
expression at the transcriptional level. Since SIRT1 is a protein deacetylase, one 
possibility is that SIRT1 deacetylates and activates DNA-binding proteins in a 
transcriptional complex on COX2 gene promoter, thus leading to activation of the 
COX2 gene transcription. As SIRT1 knockdown suppressed the activation of the 
COX2 promoter-driven luciferase reporter in an exogenous plasmid (Figure 19A), 
SIRT1-regulated COX2 induction may be mediated through modification of 
transcription factors or co-factors. Several transcription factors and co-factors 
have been demonstrated to be deacetylase substrates of SIRT1 in a variety of 
tissues and cell types in a tissue and cell specific manner. These transcription 
factors or co-factors include NFB, p53, FOXO, and PGC-1 (74-75, 131-132). 
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Notably NFB and p53 have been implicated in the regulation of COX2 gene 
expression (19, 133) (137) (138). Unfortunately my preliminary studies were 
unable to detect direct effect of SIRT1 on NFB or p53 in renal medullary 
interstitial cells.  
  To summarize, SIRT1 and COX2 are essential survival factors that are co-
localized in the renal medullary interstitial cells. One of the mechanism by which 
SIRT1 exerts its cytoprotective role in the renal medulla is through increasing 
COX2 expression in the renal medullary interstitial cells. COX2 derived PGE2 
may activate EP4 receptor, triggering downstream anti-apoptotic signaling 
pathways in the interstitial cells. Locally diffused PGE2 may also protect the 
adjacent renal tubular and vascular cells. However, the present study was unable 
to identify the molecular mechanism by which SIRT1 regulates COX2 expression. 
Further experiments are required to determine which molecule or molecules 
mediate the interaction between SIRT1 and the COX2 promoter in the renal 
medullary interstitial cells. 
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CHAPTER V 
 
RENAL MEDULLARY INTERSTITAL COX2 IN THE REGULATION OF RENAL 
SODIUM EXCRETION AND BLOOD PRESSURE 
 
Introduction 
 
Besides playing a critical cytoprotective role, renal medullary COX2 participates 
in the regulation of sodium balance and blood pressure (45) (43) (44). COX 
inhibiting NSAID was associated with the development of edema, systemic 
hypertension or impaired blood pressure control in patients with preexisting salt 
sensitive hypertension (24). Furthermore, animal studies show that high salt diet 
increases renal medullary COX2 expression (41) (42), and that selective renal 
medullary COX2 inhibition via an intra-medullary infusion catheter significantly 
increases blood pressure in uninephrectomized rats on a high salt diet (43). This 
suggests an important role of renal medullary COX2 in renal response to sodium 
loading. However, the cellular location of COX2 induction in the renal medulla 
following high salt diet has not been clearly defined.  
Nor is the signaling mechanism by which a high salt diet induces renal 
medullary COX2 expression fully established. The 5’ flanking region of the COX2 
gene possesses consensus sequences for several transcriptional factors, 
including CRE, NFB and NF-IL6 (25). Regulation of COX2 gene expression by 
these transcription factors has been shown to be cell type and stressor specific.  
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Interestingly, an increase of tonicity has been reported in the renal medulla of 
mice on a high salt diet (139-140) (141), and in vitro studies have demonstrated 
that hypertonicity activated NFB signaling is essential for COX2 induction in 
renal medullary interstitial cells (19), supporting a role for NFB signaling in high 
salt diet induced COX2 expression in renal medulla. NFB is a group of nuclear 
transcriptional factor that are normally sequestered in the cytoplasm of 
unstimulated cells as inactive homo- or heterodimers by a group of inhibitory 
proteins — IBs. Phosphorylation of IB by IKK leads to disassociation of IB 
from NFB and degradation of IB, allowing translocation of NFB into the 
nucleus and binding to DNA. Bortezomib, a NFB inhibiting drug for treating 
multiple myeloma by acting as a proteasome inhibitor that inhibits the 
degradation of IB and activation of NFB, has been reported to cause edema in 
patients, consistent with a potential role of NFB in regulating body sodium and 
fluid balance.  
  In this chapter, we examined renal medullary NFB activity following a sodium 
loading as well as its role in renal medullary COX2 induction via two approaches: 
(1) use of transgenic NFB reporter mice to determine the activation of NFB as 
well as its cellular location; (2) use of an NFB inhibitor IMD-0354 to examine 
whether NFB is required for high salt diet induced medullary COX2 expression. 
Furthermore, whether global inhibition of COX2 activity by using selective COX2 
inhibitor might cause sodium retention and hypertension in a high salt diet mouse 
model was also examined.   
84 
 
Results 
 
High salt diet induces COX2 expression in renal medullary interstitial cells 
Renal medullary COX2 expression was substantially increased after 2 days of 
high salt diet, and remained elevated throughout the study (Figure 23a and 23b). 
On the contrary, COX1 immunoreactive protein level was constitutively high, and 
not altered by high salt diet.  
To examine the cellular location of COX2 expression in the renal medulla 
following high salt diet, in situ hybridization was performed. COX2 mRNA 
expression was primarily localized in the renal medulla (Figure 23c), specifically 
in renal medullary interstitium between renal tubules. COX1 mRNA was 
constitutively expressed in the renal medulla, but was detected primarily in the 
collecting ducts. 
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Figure 23. High salt diet increases renal medullary COX2 expression. (a) Immunoblotting 
was performed to examine the COX2 expression in the renal medullary tissues of C57Bl6/J 
mice fed with high salt diet (8% NaCl) or normal salt diet (0.4% NaCl) for 3 days. Expression of 
-actin was also examined as a loading control. Each lane represents an individual mouse 
sample. (b) C57Bl/6J mice were fed with high salt diet for 0, 1, 2, 3 or 7 days. Renal medullary 
COX2 and COX1 protein expression was determined by immunoblotting. (c) In situ 
hybridization of COX1 (A, B, C) and COX2 (D, E, F) in the renal medulla of C57Bl6/J mice fed 
with normal salt diet (A, D) or high salt diet (B, C, E and F) for 5 days. (NS, normal salt diet; 
HS, high salt diet).  
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Cryostat sections from the kidneys of mice fed with high salt diet were 
examined by co-immunofluorescence staining using antibodies against COX2 
and distinct cell markers for different structures in renal medulla: AQP2 for 
collecting duct, AQP1 for thin descending limb of Henle’s loop, ClC-K channel for 
thin ascending limb of Henle’s loop, CD31 for vasa recta, and Tam-Horsfall 
protein (THP) for thick ascending limb in outer medulla. Results revealed 
perinuclear localization of COX2 in the inner medullary cells that were arranged 
in rows, which are typical renal medullary interstitial cells (Figure 24). COX2 
immunofluorescence did not co-localize with any of the cell markers used, 
suggesting that COX2 is localized exclusively in renal medullary interstitial cells. 
Additionally, COX2 induction was not observed in the renal outer medulla, as no 
COX2 immunofluorescence co-localized with THP at the same renal region.   
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Figure 24. High salt diet induces COX2 expression in the renal medullary interstitial 
cells. C57Bl6/J mice were fed with high salt diet for 3 days. The cellular location of COX2 
expression in the renal medulla was examined by co-immunofluorescence staining using the 
antibody against COX2 in red and different antibodies respectively against distinct structure 
markers in green: AQP2 for collecting duct (A and B); AQP1 for thin descending limb (E and 
F); ClC-K for thin ascending limb(C and D) and CD31 for vasa recta (G and H). (VR, vasa 
recta; * endothelial cell body)   
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High salt diet induces NFB activation in renal medullary interstitial cells 
To further investigate the molecular mechanisms that induces COX2 expression 
in renal medullary interstitial cells following a sodium loading, we examined if 
NFB signaling was activated in the kidney of high salt diet fed mice. Transgenic 
mice carrying an NFB response promoter driven a luciferase reporter were fed 
with normal salt diet or high salt diet for 3 days, and then sacrificed. High salt diet 
significantly increased luciferase reporter activity in the renal medulla by 7 fold 
compared to normal salt diet (Figure 25a, 36261045 vs 513248 unit/mg protein, 
n=10, P<0.05), indicating that NFB is activated in renal medulla following high 
salt diet. 
To determine the cellular location of NFB activation, cryostat sections of the 
kidneys from transgenic mice carrying an EGFP reporter driven by an NFB 
response promoter either on normal salt diet or high salt diet were examined by 
immunofluorescence staining using anti-EGFP antibody. Strong EGFP 
immunofluorescence was only detected in mice fed with high salt diet, but not in 
mice on normal salt diet (Figure 25b). In addition, the EGFP expression was 
mainly localized in the renal medullary cells that were arranged in rows, which 
are typical renal medullary interstitial cells. 
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Figure 25. High salt diet activates NFB in renal medullary interstitial cells. NFB 
response promoter driven luciferase (a) or EGFP (b) reporter transgenic mice were fed with 
normal salt diet or high salt diet for 3 days. (a) Luciferase activity in the renal medulla was 
determined using the Promega luciferase assay kit to assess endogenous NFB activity. 
Protein content was also measured by BCA protein assay for normalization (* P<0.05, n=15, 
student’s t test). (b) The cellular location of NFB activation was examined by 
immunofluorescence staining using the antibody against NFB reporter EGFP. Arrows indicate 
the EGFP expressing cells that are arranged in rows, which are typical renal medullary 
interstitial cells. 
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NFB activation is required for high salt diet induced renal medullary COX2 
expression To find out whether NFB mediates renal medullary COX2 induction 
following high salt diet in vivo, mice were treated with NFB selective inhibitor 
IMD-0354 to block NFB activation. Treatment with the NFB inhibitor IMD-0354 
significantly attenuated COX2 induction following high salt diet (Figure 26a), 
suggesting that NFB activation is essential for renal medullary COX2 induction. 
Consistently, the NFB inhibitor also significantly reduced high salt induction of 
urinary PGE2 production following high salt diet (Figure 26b, 809±267 vs 
1798±578 pg/24h, n=3, P<0.05). 
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Figure 26.  NFB activation is required for renal medullary COX2 induction following 
high salt diet. (a) C57Bl/6J mice were pretreated with NFB inhibitor IMD-0354 (8mg/kg bw 
daily) or vehicle for 2 days, then fed with high salt diet (8% NaCl) or kept on normal salt diet 
(0.4% NaCl) in addition to IMB-0354 or vehicle treatment for another 3 days. COX2 
expression in the renal medullary tissues was determined by immunoblotting. Each lane 
represents an individual mouse sample. (b) C57Bl/6J mice were put in the metabolic cages 
and treated in the same way as in (a). 24 hour urine of each mouse was collected at the last 
day of the experiment. Urinary PGE2 production was measured by using Cayman ELISA kit. (* 
P<0.05, n=3, ANOVA) (NS, normal salt diet; HS, high salt diet)  
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Global COX2 inhibition failed to cause sodium retention or hypertension in 
high salt diet fed mice Intra-medullary infusion of COX2 inhibitors causes 
sodium sensitive hypertension in uninephrectomized rats (43), suggesting a role 
for renal medullary COX2 in regulating sodium excretion and blood pressure. To 
further confirm this, we examined the effect of global COX2 inhibition on renal 
sodium excretion and blood pressure in a more physiologically relevant high salt 
diet fed mouse model. Male C57Bl/6J mice at the age of 2 months were 
implanted with a catheter in their artery to remotely real time monitor blood 
pressure. Mice were first kept on normal salt diet (0.4% NaCl) for one week and 
then switched to high salt diet (8% NaCl) with or without selective COX2 inhibitor 
SC58236 treatment (1:5,000 dilution in drinking water according to 
pharmaceutical company's recommendation). Daily 24 hour mean arterial blood 
pressure (MAP) of each mice was recorded. High salt diet was unable to 
increase MAP (Figure 27a), which is consistent with existing evidence suggesting 
that the blood pressure of C57 mouse strain is sodium insensitive. In addition, 
the COX2 inhibitor didn't produce significant effect on the MAP (Figure 27a). 
  In contrast to C57 background, the blood pressure of 129 mouse strain is 
reported to be sodium sensitive. Male 129/SvJ mice at the age of 2 months were 
treated with high salt diet with or without COX2 inhibitor. Systemic blood 
pressure (SBP) of each mouse was measured by tail cuff. As expected, these 
mice developed hypertension following high salt diet (Figure 27b). However, 
COX2 inhibitor SC58236 didn't produce any significant effect on the increase of 
93 
 
blood pressure following sodium loading, nor on the recovery of blood pressure 
after the mice were placed back on their normal diet (Figure 27b).  
  Additionally, several attempts failed to show any effect of global COX2 inhibition 
on urinary sodium excretion in neither C57Bl/6J or 129/SvJ mice on a high salt 
diet using metabolic cage studies (data not shown). 
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Figure 27. Global COX2 inhibition has no effect on blood pressure of high salt diet fed 
mice. (a) Telemetry recording of mean arterial pressure (MAP) of high salt diet fed C57Bl/6J 
male mice with or without selective COX2 inhibitor (SC58236 in drinking water) (n=8). (b) Tail 
cuff recording of systemic blood pressure (SBP) of high salt diet fed 129/SvJ mice with or 
without selective COX2 inhibitor (SC58236 in drinking water).  
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Discussion 
 
Renal medullary COX2 induction has been suggested to play a role in renal 
response to a sodium loading (43) (44). To further examine the physiological 
roles of high salt diet-induced renal medullary COX2 expression, the present 
study examined the cellular location of COX2 induction and found that the renal 
medullary interstitial cells are the major site of COX2 induction following high salt 
diet. In addition, NFB activation is demonstrated to play a critical role in 
mediating high salt diet induced COX2 expression in renal medulla. However, 
global inhibition of COX2 activity did not show any effect on neither renal sodium 
excretion nor blood pressure of mice on a high salt diet. 
  The cellular localization of the two isoforms of COX within the kidney has been 
documented (24). COX1 is predominantly expressed in the collecting ducts, while 
COX2, the inducible form of COX, is predominantly expressed in the renal 
medulla and the cortical thick ascending limb/macula densa. COX2 expression in 
the cortical thick ascending limb/macula densa can be induced by low salt diet or 
in certain conditions with volume contraction. On the other hand, renal medullary 
COX2 is induced under stressed conditions like water deprivation and obstructive 
nephropathy, or following high salt diet. The present study co-stained COX2 with 
the markers of distinct structures in renal medulla, and demonstrated high salt 
diet induced COX2 expression exclusively in renal medullary interstitial cells. 
Renal medullary interstitial cells are essential components of the kidney that 
participate in regulating sodium balance and maintaining blood pressure (142). 
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Chemical ablation of these cells with bromoethylamine (BEA) leads to systemic 
hypertension (36). By locating high salt diet induced COX2 in these cells, my 
work suggests that the underlying mechanisms of an important physiological role 
of renal medullary interstitial cells in regulating blood pressure may involve a 
sodium loading responsive COX2 interstitial cell expression. Although COX2 was 
first cloned in endothelial cells, COX2 immunoreactive protein was not detected 
in vasa recta of renal medulla. 
COX2 expression can be regulated at multiple levels, including transcriptional 
and post-transcriptional regulation (143). The present study demonstrated a 
critical role of a known transcriptional regulator of COX2 gene, NFB, in 
mediating high salt diet induced COX2 expression in renal medullary interstitial 
cells. High salt diet is reported to increase renal medullary NaCl concentration 
(139-141). Previous studies show that hypertonic induction of COX2 expression 
in renal medullary interstitial cells depends on NFB activation (19). Taken 
together, all the above observations suggest that high salt diet, probably through 
increasing NaCl concentration in renal medulla, activates NFB transcriptional 
activity, leading to COX2 induction in renal medullary interstitial cells. 
As a sensor of redox and energy state in the cells, SIRT1 integrates cellular 
metabolism with stress or nutritional changes. In Chapter III and IV, SIRT1 has 
been located in the renal medullary interstitial cells and some of the inner 
medullary collecting duct cells. As high salt diet increases tonicity and generates 
free radical species in the renal medulla, which are known to impact cellular 
oxidative metabolism, SIRT1 activity in the renal medulla is very likely to respond 
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to a sodium loading as well. Although NFB is reported as SIRT1 deacetylase 
substrate in other cellular contexts, preliminary studies failed to identify an 
interaction of SIRT1 with NFB in cultured renal medullary interstitial cells in the 
setting of oxidative stress, However, whether SIRT1 and NFB interact in the 
renal medullary interstitial cells in vivo following a sodium loading remains to be 
determined. Recently SIRT1 is reported to regulate the epithelial sodium channel 
expression in cultured inner medullary collecting ducts, which may suggest a role 
for SIRT1 in regulating renal sodium balance in vivo.  
Following NFB activation and COX2 induction in the renal medullary 
interstitial cells, COX2 derived prostaglandins may diffuse and act on adjacent 
renal tubular epithelial cells and vasa recta. Through activating diverse 
prostaglandin receptors and triggering a series of downstream cellular signaling 
pathways, COX2 derived prostaglandins from renal medullary interstitial cells 
may increase renal medullary blood flow and promote renal sodium excretion (45) 
(142), thus normal blood pressure can be maintained following sodium loading. 
Surprisingly, global inhibition of COX2 activity by COX2 selective inhibitor 
SC58236 did not cause sodium retention or increased blood pressure in two 
different mouse strains (C57Bl/6J and 129/SvJ) on high salt diet. One possibility 
is that inhibition of COX2 activity in vasculature, kidney macula densa may 
counteract the effect of COX2 inhibition in renal medullary interstitial cells. In 
particular, the kidney macula densa COX2 may have a pro-hypertensive effect 
through its role in promoting renin release (109). A better strategy is to generate 
a mouse with COX2 gene conditionally disrupted in renal medullary interstitial 
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cells. To achieve this, we generated a renal medullary interstitial cell specific 
inducible Cre mouse, Tenascin-C promoter driven inducible Cre knockin mouse 
(see Chapter VI). By crossing the floxed COX2 mice which have been available 
to us, with this renal medullary interstitial cell specific Cre mice, the effect of renal 
medullary interstitial cell COX2 ablation on renal ability to excrete excess sodium 
and maintain blood pressure following dietary sodium loading can be further 
examined. 
In summary, my work has demonstrated that high salt diet induced COX2 
expression in renal medulla is exclusively localized to the interstitial cells and 
nuclear factor NFB plays an important role in inducing COX2 expression in 
these cells. Since renal medullary COX2 is suggested to regulate renal sodium 
balance and blood pressure, the present study also implies a role of renal 
medullary NFB signaling in the regulation of renal sodium balance and blood 
pressure. Inhibition of renal medullary NFB may hence contribute to altered 
sodium balance in patients taking NFB inhibitors, such as  Bortezomib. 
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CHAPTER VI 
 
A RENAL MEDULLARY INTERSTITIAL CELL SPECIFIC INDUCIBLE CRE 
MOUSE, TENASCIN-C-CreER2-EGFP KNOCKIN MOUSE 
 
Introduction 
 
As previously mentioned, in addition to structurally supporting the renal tubules 
and vessels, RMICs are thought to have important physiological functions. 
RMICs are characterized by abundant cytoplasmic lipid droplets that contain 
triglycerides, cholesterol esters and free long-chain fatty acids including 
arachidonic acid. The number, size as well as lipid component of those lipid 
droplets varies dramatically upon different physiological or metabolic state of the 
animal (7) (8), implying potential roles of RMICs in physiology and metabolism. 
RMICs are also the potential target of multiple hormones such as angiotensin II 
and endothelin, actions of which have been suggested to regulate renal 
medullary hemodynamics (144) (145). Chemical ablation of RMICs with 
bromoethylamine (BEA) leads to systemic hypertension (36), further supporting 
an indispensible role of these cells in the maintenance of blood pressure. 
  In previous chapters, important physiological roles of SIRT1 and COX2 in 
RMICs have been investigated. SIRT1 mediated COX2 expression and PGE2 
production from RMICs may act in autocrine and/or paracrine pathways to 
protect renal medullary cells from stress or injury. Renal medullary COX2 is also 
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suggested to play roles in regulating renal medullary blood flow, renal sodium 
excretion and blood pressure (24).  
Given the important roles of RMICs in kidney function, in order to study genes 
of interest particularly in those cells, we set out to generate a renal medullary 
interstitial cell specific Cre mouse. A modified Cre/LoxP-based technology where 
recombinase activity of an inducible Cre-estrogen fusion protein (CreER2) is 
dependent on tamoxifen was used (146) (147). Cre expression was driven by the 
promoter of a renal medullary interstitial cell specific gene, tenascin-C. Tenascin-
C gene is one of the four members of the tenascin family (tenascin-C, -X, -R, -W) 
that encode glycoproteins found in the extracellular matrix of many tissues, 
where they play important roles not only in supporting the tissues structurally but 
also regulating the functions of the different cells populating the extracellular 
matrix, especially when active tissue modeling during embryogenesis or re-
modeling after injury occurs (148) (149) (150). Although tenascin-C is abundantly 
expressed in the mesenchyme surrounding developing epithelia in virtually every 
organ during development, its expression in normal adult tissues is relatively low 
and highly restricted in stromal cells.  
By crossing this Cre mouse with the mouse carrying floxed gene, we sought to 
conditionally knock out the gene of interest (e.g. SIRT1 or COX2) from renal 
medullary interstitial cells. The effect of selective gene disruption in RMICs on 
renal physiology or pathophysiology can be further studied. 
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Results 
 
Tenascin-C is specifically expressed in the interstitial cells of renal inner 
medulla. Evidence supporting tenascin-C gene promoter as a candidate for 
driving Cre expression specifically in renal medullary interstitial cells are as 
follows: Tenascin-C expression is reported in adult mouse renal medullary 
stroma (151) (152) (153); Our microarray data have shown that tenascin-C 
mRNA is selectively expressed in mouse renal medullary interstitial cells versus 
renal medullary collecting duct cells (Table 1); Finally high levels of tenascin-C 
expression in the renal medullary interstitium are demonstrated by in situ 
hybridization (Figure 28). 
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Figure 28. High levels of tenascin-C mRNA expression in the mouse renal medullary 
interstitium. (a, b) Dark field in situ hybridization pictures show high levels of tenascin-C 
mRNA  in the mouse renal medulla with low levels in the renal cortex. (c, d) Bright field in situ 
hybridization pictures further show tenascin-C mRNA is highly expressed in the renal 
medullary interstitium.  
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Generation of tenascin-C-CreER2-EGFP knockin mice. Considering that the 
mouse tenascin-C gene has a 31kb intron1 (Figure 29a) that may contain 
important transcriptional regulatory elements, and heterozygous tenascin-C 
knockout mice have normal phenotypes (154) (155), we decided to knock in Cre 
directly downstream of tenascin-C gene translation start site to ensure Cre 
expression in the same pattern as endogenous tenascin-C gene.   
  Mouse genomic tenascin-C gene was obtained from a BAC library screen. The 
targeting construct included a 4kb 5’ arm comprised of 5’ region upstream of 
tenascin-C gene translation start codon in exon 2, an inducible CreER2, an IRES 
(internal ribosome entrance site)-EGFP (enhanced green fluorescence protein), a 
PGK-Neo selection cassette flanked by FRT, and a 2kb 3’ homogenous arm 
(Figure 29a). The targeting construct was linearized by Ahd I and injected into 
E14 129SvJ ES cells with established protocols. Following homologous 
recombination, the CreER2-IRES-EGFP-Neo allele was expected to be inserted 
right after the translation start site ATG (Figure 29a). ES cell clones were 
screened by southern blot analysis, and four clones were identified as correctly 
targeted (Figure 29b). Germline transmission was obtained from two of the 
correctly targeted clones (3D4 and 5C3). The genotype of the mice was 
determined by PCR of genomic DNA. Mice heterozygous for the tenascin-C-
CreER2 allele were viable, of normal size, and did not exhibit any overt 
developmental or functional abnormalities. The IRES-EGFP cDNA included in 
the targeting construct was expected to give rise to co-expression of a detectable 
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marker protein (EGFP) with the CreER2 and hence allows for detecting the 
expression of Cre in mice carrying the transgene. 
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Figure 29. Generating Tenascin-C-CreER2-EGFP Knockin Mice. (a) Targeting strategy. 
The targeting construct has a 4kb 5’ arm that locates immediately upstream of the tenascin-C 
gene ATG, an inducible CreER2, IRES-EGFP reporter, a PGK neo selection cassette flanked 
by FRT and a 2kb 3’ arm that locates after exon2. (b) Southern blots show four targeted ES 
cell clones that give expected hybridization patterns. 5’ probe and 3’ probe are indicated in 
(a).  
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EGFP is exclusively expressed in renal medullary interstitial cells of 
Tenascin-C-CreER2-EGFP mice. To test if the ectopic genes are expressed 
with the same pattern as endogenous tenascin-C gene, EGFP expression was 
examined in mice heterozygous for the tenascin-C-CreER2 allele. Abundant 
EGFP expression was observed in the inner renal medulla but not in the cortex 
or outer medulla (Figure 30a). Higher power field picture (400X) showed EGFP-
positive cells arranged in rows. Co-labeling studies showed that the EGFP did 
not co-localize with renal collecting duct marker AQP2 or descending thin limb of 
loop of henle marker AQP1 but co-localized with renal medullary interstitial 
specific COX2 (Figure 30b), consistent with selective expression of EGFP in 
renal medullary interstitial cells. EGFP was not observed in other organs or 
tissues examined including the heart, spleen, liver, skin and brain (data not 
shown). 
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Figure 30. Exclusive EGFP expression in the renal medullary interstitial cells of 
tenascin-C-CreER2-EGFP mice. (a) EGFP expression was examined in the kidney of adult 
tenascin-C-CreER2-EGFP
+/-
 mice. Yellow arrow indicates EGFP positive cells arranged like 
rug of ladder resembling renal medullary interstitial cells. (b) Co-staining with renal structural 
markers (red). AQP1, thin limb of loop of henle; AQP2, collecting duct; COX2: renal medullary 
interstitial cell specific.   
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Cre recombinase is exclusively activated in renal medullary interstitial cells 
of Tenascin-C-CreER2-EGFP mice. ROSA26-lacZ reporter mice were used to 
monitor Cre activity by virtue of -galactosidase (-gal) expression that is 
dependent on Cre recombinase mediated release of a stop codon before -gal 
cDNA. Tamoxifen (1.5mg/25g bw/day) was administered to tenascin-C-CreER+/-
/ROSA26-lacZ+/- mice at the age of 8wks continuously for two weeks. Three days 
after the last injection, -gal activity was examined in major organs was by X-gal 
staining. The recombination reporter -gal activity appeared to be highly 
restricted to the inner medulla of the kidney but not in the renal cortex or outer 
medulla (Figure 31a). -gal positive cells were arranged in a rows when 
observed under higher power field (200X). This was further confirmed by co-
labeling with renal collecting duct marker AQP2 (Figure 31b). No significant -gal 
activity was observed in the heart, spleen, liver, skin and cerebrum of the brain 
(Figure 32). However, there was detectable -gal activity in some cells between 
different layers of cerebellum (Figure 32), consistent with previous studies 
showing tenascin-C expression in the forebrain and cerebellum of adult mice 
(156). No -gal activity was detected in the renal medulla or any other organs or 
tissues of tenascin-C-CreER2+/-/ROSA26-lacZ+/- mice without tamoxifen 
treatment, suggesting no leak of the inducible Cre recombinase activity (data not 
shown). 
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Figure 31. Cre recombinase is exclusively activated in the renal medullary interstitial 
cells of tenascin-C-CreER2
+/-
/ROSA26-lacZ
+/-
 mice with tamoxifen injection. (a) X-gal 
staining shows -gal activity in the kidney of tenascin-C-CreER2
+/-
/ROSA26-lacZ
+/-
 mice with 
tamoxifen injection. (b) X-gal stained renal medullary section co-stained with renal collecting 
duct marker AQP2 (red).  
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Figure 32. Cre recombinase activity in major organs of tenascin-C-CreER2
+/-
/ROSA26-
lacZ
+/-
 mice with tamoxifen injection. Pictures of X-gal staining (200X) shows no significant 
-gal activity in the heart, spleen, liver, skin and cerebrum but in certain cells lining between 
different layers of cerebellum (indicated by yellow arrows) of tenascin-C-CreER2
+/-
/ROSA26-
lacZ
+/-
 mice with tamoxifen injection.    
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Discussion 
 
In summary, we have generated a tenascin-C-CreER2-IRES-EGFP knock-in 
mouse, and demonstrated that this mouse exhibits inner medullary interstitial cell 
specific reporter EGFP expression and inducible Cre recombinase activity in the 
kidney. The tenascin-C-CreER2-EGFP knock-in mouse is therefore able to 
induce DNA recombination specifically in the medullary interstitial cells together 
with driving expression of an EGFP reporter. Through inactivating genes of 
interest (e.g. SIRT1 or COX2) or driving ectopic gene expression specifically in 
these cells, our understanding of the functional roles of renal medullary interstitial 
cells in renal physiology and pathophysiology should be greatly facilitated.  
  In Chapter V, global inhibition of COX2 activity failed to cause sodium retention 
or promote hypertension in high salt diet fed mice. This is contradictory to a large 
body of pre-existing evidence which provided the basis of our original hypothesis. 
One possibility is that besides renal medullary interstitial cells, treating mice with 
COX2 inhibitor orally also inhibited COX2 activity in other COX2-expressing 
tissues including cortical macula densa and vasculature. These other effects 
could counteract the effect of COX2 inhibition in renal medullary interstitial cells. 
In particular, cortical macula densa COX2 may exert a pro-hypertensive effect 
through its role in promoting renin release (109). A conditional gene targeting 
strategy provides means of specifically studying the role of renal medullary 
interstitial COX2 in medullary sodium excretion and blood pressure. Crossing 
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floxed COX2 mice with the tenascin-C-CreER2 mice should specifically delete 
the COX2 gene  in renal medullary interstitial cells.  
  Interestingly, we also observed abundant EGFP expression in the stroma of the 
developing kidney of tenascin-C-CreER2+/- mice (data not shown). This 
observation is consistent with previous studies showing tenascin-C expression in 
the stroma of the developing kidney (156). The tenascin-C-CreER2 mouse with 
an EGFP reporter may therefore also provide a tool for studying stromal cells 
during kidney development.  
  Finally elevated tenascin-C expression has been suggested to play important 
roles in pathological conditions such as inflammation, infection and cancer in 
multiple organs including the kidney (157) (149, 153). The tenascin-C-CreER2 
mouse may also be useful for tracing the localization of tenascin-C expression in 
these pathological conditions.  
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CHAPTER VII 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
 
My thesis project has focused on a specific population of renal cells, the renal 
medullary interstitial cells, which are predominantly located in the interstitium of 
the renal inner medulla. Renal inner medulla is a very harsh environment with 
widely fluctuating and high osmolarity (over 1,000mosm), low blood flow (less 
than 5% of total renal blood flow) and low oxygen tension (less than 10mm Hg), 
which all contribute to excessive oxidative stress. It has been a longstanding 
issue to understand how the renal medullary cells manage to survive and 
function under such stressful conditions.  
  My work first examined the distribution of an anti-stress and anti-aging molecule 
SIRT1 in the kidney, and we were able to show that SIRT1 is preferentially 
expressed in the renal inner medulla including the renal medullary interstitial cells. 
The heterogeneous expression pattern strongly implied that SIRT1 may be 
uniquely needed for cells living in such a hostile environment in the renal inner 
medulla. Through a series of in vitro as well as in vivo experiments, I gathered 
data supporting a potent anti-oxidant role of SIRT1 in the renal medullary cells. 
SIRT1 deficiency accentuates renal medullary cell apoptosis and renal fibrosis 
and conversely SIRT1 activation promotes the resistance of renal medullary cells 
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to oxidative stress both in vitro and in vivo. Further studies demonstrated that 
one of the principal mechanisms by which SIRT1 mediates its protective effects 
in renal medullary interstitial cells is through increasing COX2 expression and 
PGE2 production. COX2 derived PGE2 production may in turn act through 
autocrine and/or paracrine pathways to protect renal medullary cells from stress 
or injury. Previous studies by our lab as well as by other groups have 
demonstrated that COX2 is an essential factor for renal medullary interstitial cell 
survival under hypertonic stress. By showing that SIRT1 and COX2 co-localize in 
the renal medullary interstitial cells and that SIRT1 regulates COX2 expression in 
the setting of oxidative stress, my work has linked these two important survival 
factors uniquely in the renal medullary interstitial cells. Taken together, these 
findings in Chapter III and IV are of interest and importance, as the identification 
of SIRT1 as a molecule that confers cytoprotection in the renal inner medulla, 
and the delineation that such protection is in part mediated through COX2 and 
production of PGE2, have contributed to our understanding of the protective 
mechanisms in these "born-tough" renal medullary cells.  
  In addition to structurally supporting adjacent renal tubules and vessels, renal 
medullary interstitial cells also serve important physiological functions. A long 
ongoing project in our lab has been studying the potential roles of renal 
medullary COX2 in promoting renal sodium excretion and maintaining blood 
pressure in the renal response to a sodium loading. In Chapter V, my work has 
precisely located high salt diet induced COX2 expression exclusively in the renal 
medullary interstitial cells. COX2 derived PGE2 from these cells may promote 
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excretion of excess sodium through acting on the adjacent renal vasa recta to 
modulate renal blood flow and/or the adjacent renal tubular epithelial cells to 
modulate sodium absorption, as a result of which, normal blood pressure 
following sodium loading is maintained. The molecular mechanism by which high 
salt diet induces COX2 expression in medullary interstitial cells was further 
examined and a critical role for NFB was revealed. High salt diet activates 
NFB in renal medullary interstitial cells and inhibition of NFB significantly 
attenuates high salt diet induced COX2 expression. As high salt diet increases 
tonicity in the renal medulla and hypertonicity induced COX2 is mediated by 
NFB activation in cultured renal medullary interstitial cells, my work support a 
model whereby renal medullar interstitial cells respond to a sodium loading 
through sensing increased tonicity, which activates NFB. NFB subsequently 
mediates COX2 induction in the medullary interstitial cells, followed by production 
of locally diffusible PGE2 that coordinates the functions of vasa recta and renal 
tubules to promote renal sodium excretion and maintain body sodium balance 
and blood pressure.   
  Lastly, in chapter VI, I together with my laboratory coworkers generated a 
tenascin-C-CreER2-IRES-EGFP knockin mouse. Following careful 
characterization, we have demonstrated that this mouse has inner medullary 
interstitial cell specific reporter EGFP expression and inducible Cre recombinase 
activity. By using this tool, conditional disruption of genes of interest (e.g. SIRT1 
or COX2) in renal medullary interstitial cells is now possible. Our understanding 
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of the physiological roles of renal medullary interstitial cells as well as the 
underlying molecular mechanisms in these cells may be greatly facilitated. 
 
Future Directions 
 
The molecular mechanism by which SIRT1 regulates COX2 transcription In 
Chapter IV, my data suggest that the cytoprotective function of SIRT1 is partially 
attributable to its regulation of COX2 expression in the renal medullary interstitial 
cells in the setting of oxidative stress. However, the molecular mechanism by 
which SIRT1 regulates COX2 expression remains to be determined in future 
studies.  
  The expression of COX2 gene can be regulated at multiple levels including 
transcription, mRNA stability, translation and protein stability. The present 
findings are further supportive of a regulatory role of SIRT1 on COX2 gene 
transcription, as SIRT1 knockdown reduced both H2O2-induced COX2 mRNA 
expression and COX2 protein induction (Figure 18B), and COX2 promoter-driven 
luciferase reporter activation following H2O2 was also attenuated by SIRT1 
knockdown (Figure 19A). Considering SIRT1 is a protein deacetylase but not a 
direct DNA interacting protein, SIRT1 activity might deacetylate other nuclear 
proteins (e.g. histones, transcription factors, co-factors) which bind to COX2 
gene promoter and modulate the transcription of COX2 gene. Additionally, SIRT1 
knockdown suppressed the activation of the COX2 promoter-driven luciferase 
reporter in an exogenous plasmid with no histones bound (Figure 19A), 
suggesting that the mediator responsible for SIRT1-regulated COX2 induction 
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may be transcription factors or co-factors. ChIP assay showed physical 
association of SIRT1 with COX2 promoter DNA under both normal condition and 
stressed condition (Figure 33A). Quantitative real time PCR may be performed to 
determine if association of SIRT1 with this DNA region increases or decreases 
following oxidative stress. Nonetheless, it is possible that different machineries 
are involved in SIRT1 regulation of COX2 gene transcription under normal versus 
stressed conditions. For instance, SIRT1 may interact with a repressor under 
normal condition, while with an activator under stressed condition. Previous 
studies (19, 25) together with the present study suggest that COX2 induction is a 
pre-requisite for renal medullary interstitial cell survival from stresses. Notably, 
excessive COX2 expression is also known to induce cell apoptosis. Therefore a 
firm and precise control of COX2 expression is essential for cell vitality. By 
residing on COX2 promoter and interacting with different nuclear factors that bind 
to COX2 promoter under different conditions, SIRT1 may play an important role 
in achieving the finest control of COX2 expression in the renal medullary 
interstitial cells.  
  In search of the responsible "nuclear factor" or "nuclear factors" that mediate 
the function of SIRT1 in regulating COX2 gene transcription, several 
transcriptional regulators of COX2 gene that are also reported SIRT1 
deacetylase substrates are considered potential candidates. These transcription 
factors include NFB and p53. Preliminary data, however, were not supportive of 
a role of SIRT1 in modifying either NFB or p53 in the cultured RMICs. Co-
immunoprecipitation was unable to detect direct association of SIRT1 with either 
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p65 or p53. Acetylation level of p65 was not affected by knockdown of SIRT1 by 
SIRT1 selective shRNA or activation of SIRT1 by SIRT1 activators. In addition, 
H2O2 treatment didn't induce the activation of the luciferase reporter driven by a 
NFB response promoter, HIV long-terminal repeat (LTR) (158), indicating that 
NFB signaling may not be responding to H2O2 treatment in the context tested. 
Interestingly, the levels of both total p53 and acetylated-p53 significantly 
increased following H2O2 treatment, consistent with a role for p53 in mediating 
cellular response to stress. However, knocking down SIRT1 expression or 
activating SIRT1 had no significant effect on H2O2-induced either total p53 level 
or acetylated-p53 level. Taken together, all the above observations do not 
support a direct modification of either p65 or p53 by SIRT1 activity in the cultured 
RMICs in the setting of oxidative stress.   
  In order to further explore candidates that mediate the interaction between 
SIRT1 and COX2 promoter region, I searched for putative transcription factor 
binding elements on the COX2 promoter region using VISTA tools 
(http://genome.lbl.gov/vista/index.shtml). Interestingly, in an evolutionarily 
conserved ~100bp genomic DNA region (among human, dog, rat and mouse) 
located at around 800bp upstream of COX2 gene transcription start site, there 
are two adjacent putative FOXO binding elements (Figure 33B). The mammalian 
FOXO family comprises three major members of transcription factors, FOXO1, 
FOXO3 and FOXO4, which can associate with a variety of unrelated 
transcriptional factors and regulate activation or repression of diverse target 
genes that play crucial roles in diverse cellular processes including proliferation, 
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apoptosis, stress resistance and metabolic regulation (159). Importantly, FOXO3 
expression was observed in both mouse renal medulla in vivo and in cultured 
mouse renal medullary interstitial cells in vitro by RT-PCR (Figure 33C). The 
expression of FOXO3 in the renal medulla was also confirmed by in situ 
hybridization (data not shown). Of note, FOXO3 is also a deacetylase substrate 
of SIRT1 and SIRT1 has various effects on FOXO3-mediated gene expression, 
from activation to repression (132)  (160). Based on the above observations, I 
hypothesize that FOXO3 may be "the transcription factor" that binds to COX2 
promoter region and mediates the function of SIRT1 in regulating COX2 
expression. Importantly, ChIP assay has shown that both SIRT1 and FOXO3 
were detected in association with COX2 promoter region (Figure 33A). To 
confirm whether SIRT1 and FOXO3 are present in the same transcriptional 
complex on the COX2 promoter, reciprocal reChIP may be performed by 
immunoprecipitating the protein/DNA complex first with anti-SIRT1 antibody and 
then immunoprecipitating for the second time with anti-FOXO3 antibody, and vice 
versa. H2O2 treatment induced FOXO3 disassociation with this COX2 promoter 
region (Figure 33A), suggestive of a suppressive role for FOXO3 in regulating 
COX2 gene transcription. Further experiments should determine the effect of 
SIRT1 knockdown or SIRT1 activation on total and acetylated-FOXO3 levels. By 
using FOXO3-overexpressing plasmids or FOXO3 selective shRNA, I will also 
examine the effect of FOXO3 overexpression or FOXO3 knockdown on COX2 
expression.  
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Figure 33. FOXO3 and SIRT1 associate with the same region of the COX2 promoter. (A) 
ChIP assay showed physical association of SIRT1 and FOXO3 with COX2 promoter region [-712, 
-396] in non-treated or H2O2-treated cultured renal medullary interstitial cells. (B) In an 
evolutionarily conserved genomic DNA region located at ~800bp upstream of COX2 gene 
transcription start site, there are two adjacent putative FOXO binding elements. (C) RT-PCR 
analysis showed FOXO3 mRNA expression was present in the renal cortical tissue, renal 
medullary tissue, and cultured renal medullary interstitial cells of mice.  
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Renal medullary interstitial cell specific gene ablation using Tenascin-C-
CreER2 mice In Chapter VI, we generated a Tenascin-C-CreER2 knockin 
mouse that has inducible Cre recombinase selectively expressed in the renal 
medullary interstitial cells. This novel tool will be actively used in the further 
studies on the roles of COX2 and/or SIRT1 in the renal medullary interstitial cells.   
  As I have discussed briefly in the discussion section of Chapter V, unexpectedly, 
global inhibition of COX2 by treating mice with pharmacological inhibitors didn't 
cause sodium retention or increased blood pressure (Figure 27) following sodium 
loading. One possible explanation is that inhibition of COX2 activity in the 
vasculature and/or renal cortical thick ascending limb (macula densa) may 
counteract the effect of inhibiting COX2 activity in the renal medullary interstitial 
cells. In particular, COX2 activity in macula densa is pro-hypertensive through 
promoting renin release (109), as opposed to a suggested anti-hypertensive role 
of COX2 in the renal medullary interstitial cells. In order to specifically study the 
role of COX2 in the renal medullary interstitial cells, conditional renal medullary 
interstitial cell specific COX2 knockout mice will be generated by crossing renal 
medullary interstitial cell specific Cre mice (Tenascin-C-CreER2 mice) with 
floxed-COX2 mice. Renal sodium excretion and blood pressure following sodium 
loading will be further examined in these conditional COX2 knockout mice. 
Previous studies have suggested an important role of renal medullary interstitial 
COX2 in promoting renal sodium excretion and maintaining blood pressure 
following sodium loading, I thus expect that the renal medullary interstitial cell 
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COX2 knockout mice will have impaired renal ability to excrete excess sodium 
and will develop hypertension following high salt diet.  
  This Tenascin-C-CreER2 mouse will also be crossed with a floxed-SIRT1 
mouse to generate conditional renal medullary interstitial cell specific SIRT1 
knockout mice for further studies on the role of renal medullary interstitial cell 
SIRT1. As compared to SIRT1 heterozygous mice with globally one SIRT1 allele 
ablation, renal medullary interstitial cell specific SIRT1 knockout mice have both 
SIRT1 alleles deleted in the renal medullary interstitial cells. Therefore these 
SIRT1-null renal medullary interstitial cells are expected to be more vulnerable to 
stress or injury and develop severer phenotypes, when compared with SIRT1-
deficient cells. Secondly, although the in vivo observations in Chapter III have 
clearly supported a protective role of SIRT1 against UUO induced apoptosis, the 
present study didn't distinguish the role of renal medullary interstitial cell SIRT1 
from potential roles of SIRT1 in other tissues (e.g. renal medullary collecting duct 
cells, inflammatory cells). Previous studies show an anti-oxidant function of 
SIRT1 in the cultured renal tubular cells (90), suggesting that renal medullary 
collecting duct cell SIRT1 may also be protective against UUO injury. SIRT1 
activity in inflammatory cells, on the other hand, can be complicated. SIRT1 is 
reported to inhibit inflammatory responses (90), however, the yin-yang roles that 
inflammation plays during UUO injury have not been fully understood yet and are 
still under debating. Taken together, conditional renal medullary interstitial cell 
specific SIRT1 knockout mice should offer significant advantage for future 
studies versus SIRT1 heterozygous mice. SIRT1-null renal medullary interstitial 
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cells should exhibit a more pronounced phenotype and concerns regarding 
SIRT1 activity in other tissues will be mitigated.  
 
Potential role of SIRT1 in renal response to sodium loading As discussed in 
Chapter III and Chapter IV, SIRT1 is abundantly expressed in the renal medullary 
interstitial cells. SIRT1 mediated COX2 induction protects renal medullary 
interstitial cells following oxidative stress or renal injury from obstructive 
nephropathy. Renal medullary interstitial cells were also shown to be the major 
site of renal medullary COX2 expression in a high salt diet mouse model in 
Chapter V. Although my preliminary data using a COX2 selective inhibitor to 
globally inhibit COX2 activity did not affect renal sodium excretion or blood 
pressure in mice on a high salt diet, many other studies have suggested an 
important role of renal medullary COX2 in regulating renal blood flow, renal 
sodium excretion and blood pressure. In addition, high salt diet increases tonicity 
and generates free radical species in the renal medulla. This impairs cellular 
oxidative metabolism. Based on the above observations, considering that SIRT1 
is a regulator of COX2 expression in renal medullary interstitial cells and that 
SIRT1 is sensitive to cellular redox state, it is of interest to explore if SIRT1 plays 
a role in high salt diet induced COX2 expression in renal medullary interstitial 
cells and whether SIRT1 participates in the renal regulation of sodium excretion 
and blood pressure following sodium loading.  
  Preliminary data using a naturally producing SIRT1 activator resveratrol have 
suggested a potential role of SIRT1 activation in promoting urinary sodium 
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excretion in high salt diet fed mice (Figure 34). Further experiments should 
examine the effect of SIRT1 activation by more specific small molecule SIRT1 
activator SRT compounds or SIRT1 deficiency by using heterozygous SIRT1 
knockout mice on renal sodium excretion as well as blood pressure following 
sodium loading. With regard to the underlying mechanism by which SIRT1 
activation might promote renal sodium excretion, SIRT1 regulation of renal 
medullary interstitial COX2 induction following high salt diet could be examined.  
  Besides a potential role of renal medullary interstitial SIRT1, the possibility that 
collecting duct SIRT1 may participate in regulating renal sodium balance by 
affecting epithelial sodium reabsorption must also be considered, since SIRT1 
expression is observed in some renal medullary collecting duct cells in vivo. 
Furthermore, SIRT1 has been reported to regulate the expression of the -
subunit of the epithelial sodium channel ENaC in cultured inner medullary 
collecting duct cells. 
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Figure 34. Resveratrol promotes urinary sodium excretion in mice fed with high salt 
diet. 12 C57Bl/6J male mice were fed with low salt diet and kept in metabolic cages. Each 
mouse was fed with a certain amount of food everyday to control the daily sodium intake. 
Daily urine was collected for electrolyte measurement for urinary sodium output 
throughout the study. After 7 days in the metabolic cages for balance, Sirtuin-1 activator 
Resveratrol was administered to 6 mice by gavage (shown in purple line), and vehicle to 
the other 6 mice (shown in blue line). 4 days later, all the mice were switched to high salt 
diet for another 7 days. Resveratrol treated mice excreted excess sodium more promptly 
than vehicle treated mice following high salt diet. 
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Potential Role of SIRT1 in Renal Aging or Metabolic Renal Disease My work 
has demonstrated an important anti-oxidant function of SIRT1 activity in the renal 
medulla and suggests that targeting SIRT1 with pharmaceutical activators could 
provide a strategy to maintain renal function in conditions that induce oxidative 
stress in the renal medulla such as ureteral obstruction. Aging and diseased 
conditions such as the metabolic syndrome, increase oxidative stress in the 
kidney and are associated with impaired renal function (22). Given the important 
roles of SIRT1 in the biology of aging and metabolism, it will be important to 
determine if SIRT1 activation also prevents renal aging or protects renal cells in 
metabolic renal disease such as diabetic nephropathy or hypertensive 
nephropathy.  
  To study the role of SIRT1 in renal aging, we first asked if renal SIRT1 
expression is reduced with aging. Preliminary data show that although renal 
SIRT1 expression was not significantly different in C57Bl/6J mice during 
adulthood (3, 5, 10, 18 months), decreased renal SIRT1 expression in mice was 
observed at 26 months of age (data not shown). This observation is concordant 
with previous studies showing that age related renal changes in mice are minimal 
until an age of at least 22 months (114) (115). Interestingly, reduced renal SIRT1 
expression was also observed in mice on a high fat diet (data not shown). 
However, whether the reduction of SIRT1 expression contributes to renal 
damage and reduced renal function with aging or in metabolic syndrome remains 
to be investigated.  
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